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DNA methyltransferases (DNA MTases) are enzymes responsible for DNA 
methylation (transfer of methyl groups to a base in the DNA) and are vital for the 
development of mammals. Several MTases have been identified in eukaryotes 
but the most abundant is Dnmt1. Furthermore, many pathological conditions are 
often attributed to an altered availability or function of this enzyme, however the 
understanding of the regulation of Dnmt1 and the concomitant relationship to 
diseases is far from being complete. In mammals the methylation of DNA 
correlates with gene activity, and methylation patterns change dramatically during 
early development when the genome of the mammalian embryo undergoes 
consecutive waves of demethylation (loss of methylation) and de novo 
methylation (methylation of DNA sites that have not been previously methylated). 
The hypothesis of this study was that alternative Dnmt1 isoforms are expressed 
at specific developmental stages and thus contribute to changes in the DNA 
methylation pattern. To study this regulation the structure of the Dnmt1 gene was 
determined. In this work, the tissue distribution and abundance of Dnmt1 mRNA 
was analyzed by Northern blot and a new, longer transcript was identified that is 
present in testis and skeletal muscle tissue. The novel isoform was cloned by a 
combination of RT-PCR and RACE techniques and found to be identical in both 
tissues. This new isoform differs from the ubiquitous cDNA in the 5’ end, utilizing 
a new transcriptional start site and an 800 bp long alternative first exon. The 
cellular localization of this new transcript was determined by in situ hybridization 
and found to be present in the more specialized haploid spermatogenic cells, 
spermatids and at lower level in skeletal muscle. During muscle differentiation, 
the ubiquitous isoform is downregulated while the alternative isoform is 
upregulated. Although this mRNA codes for several short upstream ORFs which 
could prevent translation of the Dnmt1-specific ORF, it was found by 
immunofluorescence and Western blot analyses that this transcript can be 
translated in vivo producing a shorter Dnmt1 protein. The results shown here 
indicate that alternative Dnmt1 isoforms are expressed in vivo and might play an 
active role in the regulation of DNA methylation.  
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Die DNA Methyltransferasen sind verantwortlich für die spezifische Methylierung von 
DNA-Basen. Mehrere DNA Methyltransferasen sind bekannt, wobei die Dnmt1 das 
hauptsächlich vorkommende Enzym ist. Bei Säugetieren korreliert die DNA-Methylierung 
mit der Genaktivität und ist essentiell für die Embryonalentwicklung. Eine beeinträchtigte 
Funktion oder Verfügbarkeit des Enzyms kann zu pathologis
führen. Die Regulation der Dnmt1 und die damit verbundene Bedeutung bei der 
Entstehung von Krankheiten ist bisher nur unvollständig untersucht. In der Frühphase der 
Embryonalentwicklung von Säugetieren ändert sich das Methylierungsmuster des 
Genoms dramatisch. In zeitlich aufeinander folgenden Phasen wird die DNA demethyliert 
(Verlust der Methylgruppen) und neu methyliert (De-Novo Methylierung). Die Hypothese 
dieser Arbeit ist, dass verschiedene Isoformen der Dnmt1 in spezifischen 
Entwicklungsstadien exprimiert werden und zu Veränderungen des 
Methylierungsmusters der DNA beitragen. Um diese Regulation zu untersuchen, wurde 
die Struktur der Maus Dnmt1-Gens bestimmt. Außerdem wurde in verschiedenen 
Gewebetypen die Transkriptionsgröße und die Transkriptionsintensität der mRNA mit 
Hilfe von Northern-Blots quantifiziert. Mit diesen Experimenten konnte im Hoden- und 
Skelettmuskelgewebe ein längeres Dnmt1 Transkript als in anderen Geweben 
identifiziert werden. Dieses neue Dnmt1-Transkript wurde mit Hilfe von RT-PCR und 
RACE-Techniken kloniert und ist in beiden Geweben identisch. Es unterscheidet sich auf 
DNA-Ebene in der Sequenz des 5’-Endes von der bisher bekannten Form der Dnmt1 und 
besitzt einen anderen Startpunkt für die Transkription. Darüber hinaus besitzt das neue 
Dnmt1-Transkript ein 800 Basenpaar großes erstes Exon, welches sich von dem des 
bekannten Dnmt1-Transkripts unterscheidet. Die spezifische zelluläre Lokalisation des 
neuen Transkripts wurde mit Hilfe der In-Situ-Hybridisierung analysiert. Mit dieser 
Technik wurde das alternative Transkript in stärker spezialisierten, haploiden 
spermatogenen Zellen (Spermatiden) und zu einem geringen Maß im Skelettmuskel 
nachgewiesen. Während der Differenzierung von Muskelzellen wurde eine verminderte 
Expression des bereits bekannten mRNA-Transkripts und eine verstärkte Expression des 
neu identifizierten mRNA-Transkripts festgestellt. Obwohl die mRNA der alternativen 
Isoform verschiedene, kurze offene Leserahmen enthält, welche die Translation eines 
spezifischen Dnmt1 Proteins verhindern könnten, wurde durch Immunofluoreszenz- und 
Western-Blot Analysen ein Translationsprodukt nachgewiesen. Nach den hier 
aufgezeigten Ergebnissen werden alternative Dnmt1 Isoformen in vivo exprimiert, welche 
eine aktive Rolle bei der Regulation der DNA-Methylierung spielen könnten. 
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1.1 DNA METHYLATION 
 
The DNA of most organisms has in addition to the four major bases; A, T, C and G, one 
or more minor bases. These minor bases are created by a modification of the DNA by 
post-replicational methylation (Riggs, 1990). 
 
1.1.1 TYPES OF DNA METHYLATION 
 
Two major classes of DNA modifications exist in nature. One class methylates a ring 
carbon in position 5 to form C5-methylcytosine (5mC). The second class methylates 
exocyclic nitrogens and forms either N4-methylcytosine or N6-methyladenine.  
In prokaryotes, the major role of DNA methylation is to protect host DNA against 
degradation by the cognate restriction enzymes. However, Escherichia coli also has two 
methylase systems that are not associated with restriction-modification systems. The 
dam gene encodes a methylase that forms 6mA and the dcm gene encodes a methylase 
that forms 5mC. Methylation has been shown not to be essential in Escherichia coli 
(Russell and Hirata, 1989), but provides useful functions. The classic function is the DNA 
modification in a restriction-modification system. Foreign DNA from a species or strain 
with a different or no methylation pattern is digested by the restriction enzyme of the host 
restriction-modification system. Some strains of Escherichia coli (e.g. K-12) are able to 
restrict methylated DNA protecting it against infections by phages which escape the 
conventional host restriction by methylating their DNA while they replicate in the host 
strains. Therefore, DNA methylation, along with restriction enzymes, function to reduce 
the efficiency of gene transfer between unrelated species. The dam methyltransferase 
(methylase or MTase) is involved in a wide variety of cellular functions such as 
postreplicative mismatch repair, control of Escherichia coli chromosome replication and 
chromosome segregation, control of plasmid replication, transposition, gene expression 
and control of the initiation of phage P1 DNA packaging (Marinus, 1984).  
In eukaryotes there is no evidence for a restriction enzyme function. All potential sites are 
methylated in bacteria but many potentially methylatable sites are unmethylated in 
eukaryotes. Unmethylated sites would be sensitive to restriction if restriction modification 
systems similar to those in bacteria were in function. Therefore, it is likely that methylation 
serves other functions in eukaryotes. In these organisms, DNA methylation has been 
implicated in the control of several cellular processes, mainly in gene regulation and thus 
in processes including differentiation and development. C5 cytosine MTases can be 
found in both prokaryotes and eukaryotes, whereas the exocyclic MTases have been 
mainly isolated from prokaryotes. In general, the 5mC modification is nearly universal 
among eukaryotes with genomes greater than 108 bp (mammals and plants), but rare 
among eukaryotes with smaller genomes (yeast, flies and nematodes) (Bestor, 1990; 
Bird, 1992). Furthermore, two C5 cytosine MTases (masc1 and masc2) with similarities to 
the mammalian MTases have been cloned from the filamentous fungus Ascobolus 
immersus (Chernov et al., 1997; Malagnac et al., 1997). DNA methylation in Ascobolus  is 
essential for the completion of the developmental processes underlying sexual 
reproduction. To date, 5mC has not been detected in the DNA of Schizosaccharomyces 
pombe (Antequera et al., 1984), Saccharomyces cerevisiae (Proffitt et al., 1984), 
Caenorhabditis elegans (Simpson et al., 1986) and Drosophila melanogaster (Urieli-
Shoval et al., 1982). Recently a MTase related Drosophila protein has been cloned, 
DmMT2, (Hung et al., 1999) which is similar to that of vertebrate Dnmt2 enzymes. This 
work focuses on the regulation of DNA methylation by the C5 cytosine MTases in 
mammals.  
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1.1.2 DNA METHYLATION REACTION 
 
The enzyme responsible for the methylation process is DNA MTase, which transfers a 
methyl group from S-adenosyl-L-methionine (SAM or AdoMet) to the 5-carbon in the 
pyrimidine ring of cytosine (Fig.1.1) (Wu and Santi, 1987). This process involves the 
formation of a transient covalent complex between the protein and the pyrimidine being 
modified (see Fig. 1.1). A cysteine thiol of the enzyme attacks the 6-carbon of cytosine 
and forms a covalent DNA-protein intermediate. The addition of the cysteine thiol 
activates the 5-carbon allowing transfer of the methyl group from SAM and release of S-
adenosyl-L-homocysteine (SAH or AdoHcy).  
 
 
Fig.1.1. Reaction pathway for C5-cytosine methyltransferase based on the 
mechanism proposed by Wu and Santi (Wu and Santi, 1987) for thymidylate 
synthase and tRNA-(uracil-5)methyltransferase. The attack on carbons 5 and 6 are 
shown in the figure. The methyl group is transferred to carbon-5 of cytosine, and the 
hydrogen located on carbon-5 is released as H+. During this reaction SAM is coverted to 
SAH. A base (B:) that abstracts a proton from carbon-5 is needed for the elimination step 
(Gerlt and Gassman, 1993). 
 
The fact that DNA contains a set of modifications that is not encoded in the genetic 
sequence but is related to changes in gene activity, classifies DNA methylation as an 
epigenetic process. The recognition sequence for the mammalian DNA MTase has also 
been identified and is highly specific with almost all cytosine methylations occurring on 5’-
C-p-G-3’ (CpG) (Gruenbaum et al., 1981) and over half of CpG dinucleotides being 
methylated in the mammalian genome (Bestor et al., 1984). It has also been found that 
cytosine methylation can occur at CpXpG trinucleotides in higher plants (Gruenbaum et 
al., 1982) and also in mammals but at lower frequency (Clark et al., 1995). 
 
1.1.3 STRUCTURE OF A C5-CYTOSINE METHYLTRANSFERASE 
 
Several aspects of the catalytic mechanism of DNA methylation have been clarified 
mainly for prokaryotic MTases (Wu and Santi, 1987). MTase HhaI is a C5 cytosine 
MTase originally isolated from the bacterium Haemophilus haemolyticus (Roberts et al., 
1976). The gene for this MTase has been cloned and sequenced and the overexpression 
of the protein in Escherichia coli (Caserta et al., 1987; Klimasauskas et al., 1990) 
followed by large-scale purification has allowed its crystallization (Kumar et al., 1992). 
The enzyme is folded into two domains (Fig.1.2): a larger catalytic domain and a smaller 
DNA recognition domain which is involved in flipping the target cytosine out and 
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positioning it into the catalytic pocket of the enzyme (Cheng, 1995) (Fig.1.2). 
 
 
Fig.1.2. Graphic representation of the complex of the MTase HhaI covalently bound 
to a 13-mer DNA duplex containing its recognition sequence. The end product of 
the reaction, SAH, is also present (yellow). The protein is shown in brown, the DNA 
backbone  in magenta, the DNA bases in green, and the active-site loop and the 
recognition loops are represented in white (right panel). The left panel is a view looking 
down the DNA helix axis, in which the DNA can be seen to lie between the large domain 
(on the right) and the small domain (on the left). On the right panel a side view from the 
minor groove is shown. (Fig. from (Cheng, 1995)). 
 
1.1.4 DNA METHYLATION AND GENE EXPRESSION 
 
The methylation of DNA helps to regulate gene expression and mistakes in this regulation 
can have drastic consequences leading to birth defects and cancer. Three possible ways 
by which DNA methylation can affect gene expression are:  
 
i) Direct effect: Methylated CpG residues can directly interfere with the binding of 
specific transcription factors to DNA. Several transcription factors (AP-2, c-
Myc/Myn, E2F and NFkB) bind to DNA sequences that include CpG sites and 
have been shown to be sensitive to methylation at these sites (TF1 in Fig. 1.3). 
Other transcription factors, however, are not sensitive to methylation (Sp1, CTF 
and YY1) (Tate and Bird, 1993) (TF2 in Fig. 1.3).  
 
ii) Direct binding of specific factors: The direct binding of specific factors to 
methylated DNA mediates repression (Fig. 1.3). Two such factors, MeCP1 
(complex of several subunits) and MeCP2, have been identified and shown to 
bind to methylated CpG in any sequence context and thereby preventing 
transcription factor binding. MeCP1 binds to DNA containing multiple 
symmetrically methylated CpG sites  (Meehan et al., 1989). MeCP2 is more 
abundant than MeCP1 and is able to bind to DNA that is asymmetrically 
methylated, with just a single methyl-CpG. In addition, the distribution of MeCP2 
on the chromosome parallels that of methyl-CpG (Lewis et al., 1992). 
Experiments on mice with a disrupted MeCP2 gene have shown that MeCP2, like 
DNA MTase is dispensable in embryonic stem cells but essential for embryonic 
development (Tate et al., 1996).  
Introduction 
 
 4
iii) Chromatin structure alteration: It has been shown that methylated DNA affects 
the positioning of nucleosomes and influences the sensitivity of DNA to DNAase I 
(Keshet et al., 1986). Further experiments using microinjection of methylated and 
non-methylated templates into nuclei have shown that methylation inhibits 
expression only after chromatin is assembled (Buschhausen et al., 1987). These 
results support the view that methylation induces a change in conformation of 
chromatin to an inactive state (Kass et al., 1997). However, only recently it has 
been shown how cytosine methylation affect the structure of chromatin (Fig. 1.3) 
by its interaction with MeCP2 (Jones et al., 1998; Nan et al., 1998). MeCP2 binds 
to chromosomes in a methylation dependent manner and mediates 
transcriptional repression. MeCP2 contains a transcriptional repression domain 
which associates with a transcriptional repression complex containing mSin3a 
and histone deacetylase (Jones et al., 1998; Nan et al., 1998). Two possible 
explanations of how this interaction works have been proposed. In the first one 
deacetylation of lysine amino groups might allow interactions between the amino 
terminal histone tails and the DNA phosphate backbone. The second possibility 
is that deacetylation might favour interactions between adjacent nucleosomes 
(Fig.1.4). 
 
 
 
Fig.1.3. A model to explain the effects of DNA methylation on transcription. 
The relevant parameters are proximity and methylation of CpG sites. The MeCP 
molecules are shown as ovals, the CpG sites as filled circles (methylated) or half 
circles (non-methylated) circles, the arrows represent transcription from the 
promoter, TF1 and 2 represent transcription factors 1 and 2, sensitive or 
insensitive to methylation, respectively and HDAC represents the histone 
deacetylase. Active transcription is indicated with an arrow.  
 
Fig.1.4. Methylation and histone deacetylation. MeCP2, a protein that binds to 
methylated DNA, exists in a complex with histone deacetylase and mSin3a. 
Nucleosomes (as several connecting disks) with  their histone tails (as thin lines coming 
out of the nucleosomes) are shown. The two mechanisms in which histone deacetylation 
changes the structure of the nucleosomes are also depicted. The deacetylation by the 
MeCP2 complex (MeCP2, mSin3a and histone deacetylase) of the lysine amino groups 
on the histone tails might allow the interaction of the histone tails and the DNA backbone 
or might lead to compaction of the chromatin by allowing the interactions between the 
nucleosomes (Figure from (Bestor, 1998)). 
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1.2 DNA METHYLATION IN NORMAL DEVELOPMENT 
AND DISEASE 
 
1.2.1 DNA METHYLATION AND DEVELOPMENT 
 
A distinct change in the degree of methylation of the genome has been observed during 
gametogenesis and early mammalian embryogenesis. While many genes are highly 
methylated in sperm DNA (Groudine and Conkin, 1985; Razin et al., 1984), genes are 
often less methylated in oocytes (Monk et al., 1987; Sanford et al., 1987) (Fig. 1.5). 
During development, the DNA of the extraembryonal membranes (yolk sac and placenta) 
becomes dramatically demethylated, while the DNA of fetal tissues is subjected to a de 
novo methylation process after implantation (Monk et al., 1987; Razin et al., 1984; 
Sanford et al., 1987). 
 
i) DNA methylation in the early embryo. Dynamic changes in the methylation 
pattern of specific genes in the early embryo were observed. CpG islands are 
regions (500-2000 bases pairs) of unmethylated DNA with a high frequency of 
CpG dinucleotides (Bird et al., 1985) and have been found to be associated with 
5’ ends of housekeeping genes and of some tissue specific genes (Bird, 1986). 
The CpG islands in housekeeping genes are unmethylated throughout 
development. However, the CpG islands in tissue-specific genes are heavily 
methylated in sperm and less methylated in the mature oocytes. Between the 4 
to 16 cell stages this methylation is erased. The unmethylated state of these 
genes persists throughout the entire preimplantation period (Howlett and Reik, 
1991; Kafri et al., 1992; Sanford et al., 1987). 
 
ii) Methylation during gametogenesis. Primordial germ cells (PGCs) emerge from 
the generally unmethylated epiblast before tissue specific de novo methylation 
takes place in the epiblast lineage, which gives rise to the embryo proper 
(somatic lineage). The trophoblast derived lineage (placenta and yolk sac) is 
substantially demethylated. The PGCs then migrate and colonize the developing 
genital ridges by 10-11 dpc (Gomperts et al., 1994). At 12.5 dpc before sexual 
differentiation of the primordial germ cells begins, tissue specific and imprinted 
genes are unmethylated (Chaillet et al., 1991; Kafri et al., 1992). This 
hypomethylated state prevails until sexual differentiation of the PGCs takes place 
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and de novo methylation occurs in the cells populating the gonads of both sexes, 
forming a bimodal pattern of methylation where CpG islands remain 
unmethylated and non-island sequences are methylated (Kafri et al., 1992). 
 
 
Fig.1.5. Methylation during gametogenesis and early development in mammals. 
The overall methylation increases during gametogenesis being higher in the male 
gametes. During cleavage, the genome undergoes global demethylation and after the 
blastocyst stage the overall methylation level remains low in the germ line and increases 
in the somatic lineage. There are therefore two waves of de novo methylation (grey 
boxes), one is during gametogenesis and the other is after implantation when tissue 
specific patterns are being established (Fig. modified from T. H. Bestor). 
 
This work is concerned with the regulation of DNA methylation during gametogenesis and 
myogenesis and focusses on the identification and characterization of alternative Dnmt1 
isoforms. 
 
1.2.2 DNA METHYLATION AND DISEASE 
 
Global changes in methylation levels as well as modification of methylation patterns of 
individual genes has been observed in a variety of tumors (Cardoso and Leonhardt, 
1999). However, the role of methylation in carcinogenesis is still not clear since both DNA 
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hypomethylation and hypermethylation have been associated with cancer (Baylin et al., 
1991; Jones, 1986).  
 
i) Epigenetic changes induced by the (cytosine-5)-DNA MTase: The mRNA 
level and enzyme activity of MTase are higher in many tumor cells than in normal 
cells (Kautiainen and Jones, 1986). However, the generally higher 
methyltransferase activity does not lead to an overall increase but rather to a 
decrease of total genomic 5mC content (Feinberg et al., 1988; Gama-Sosa et al., 
1983). When the methylation status of various genes is measured in tumor cells, 
both hypermethylation as well as hypomethylation become apparent (Counts and 
Goodman, 1995). It appears that the pattern of methylation of specific genes is 
altered in tumor cells and normally unmethylated CpG islands may become 
hypermethylated (Baylin et al., 1991).  
 
 Hypomethylation. Reduced levels of global DNA methylation have been found in 
a variety of malignancies. Growth inducing genes such as oncogenes can 
become overexpressed as a result of hypomethylation. In particular, 
demethylation and overexpression of the the c-fos, the c-myc and the c-H-ras 
proto-oncogenes are known to be involved in hepatocarcinogenesis induced by 
conditions such as methyl donor starvation (Rao et al., 1989; Wainfan and 
Poirier, 1992). 
 
 Hypermethylation. There have been reports of regional increases in DNA 
methylation levels and regional hotspots for hypermethylation on chromosomes 
3p, 11p and 17 p in a variety of human tumors have been shown (de Bustros et 
al., 1988; Makos et al., 1993). Genes involved in growth arrest and terminal 
differentiation such as the MyoD1 gene (Rideout et al., 1994) and tumor 
suppressor genes such as pRb (Greger et al., 1989; Sakai et al., 1991), bcr-abl 
(Zion et al., 1994), pVHL (Herman et al., 1994), pWT (Steenman et al., 1994), 
estrogen receptor (Lapidus et al., 1996), p57KIP2 (Hatada et al., 1996), MDG1 
(Huynh et al., 1996) and p16 (Little and Wainwright, 1995) are often found 
inactivated by either mutation or hypermethylation in tumor cells. 
Hypermethylation of tumor suppressor genes may lead to gene inactivation and 
result in a selective growth advantage of affected cells.  
 
ii) Genetic changes at the target site of (cytosine-5) DNA MTase: Cytosine 
methylation is also responsible for the induction of a high percentage of disease-
causing point mutations in tumor suppressor genes in somatic and germline cells. 
Mutations occur by spontaneous deamination of 5mC (Coulondre et al., 1978). 
Both cytosine (C) and 5mC deaminate in single- and double-stranded DNA to 
form uracil and thymine, respectively (Lindahl, 1993). However, it is more difficult 
for the cell to correct the resulting T:G mismatch since thymine, unlike uracil, is a 
normally occurring DNA base. In aqueous solution at 37oC, a 4- to 9- fold higher 
deamination frequency of 5-mC relative to C in single stranded DNA and in 
double stranded DNA a ~ 2-fold higher deamination frequency was measured for 
5mC when compared to C (Shen et al., 1994). A sophisticated DNA repair 
apparatus has evolved in mammals which catalyzes the selective repair of the T-
G mismatches (resulting from 5mC deamination) back to C-G pairs (Wiebauer 
and Jiricny, 1989; Wiebauer and Jiricny, 1990). The remaining unrepaired C to T 
transitions cause many gene mutations in humans leading to hereditary diseases 
and cancer (Green et al., 1990; Rideout et al., 1990). 
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Vertebrates and other organisms with DNA methylation show a depletion in the 
frequency of occurrence of the CpG dinucleotide, which is the predominant site at 
which 5mC is found. This depletion is thought to be due to increased 
mutagenesis as described above. 
The target cytosines of MTase in prokaryotes are mutated to thymine with an 
increased frequency when compared with non target cytosines. In eukaryotes, 
the enhanced mutability of 5mC contributes significantly to carcinogenesis and 
inherited disease (Jones et al., 1992; Laird and Jaenisch, 1994). In humans, 
several genes such as p53 (Greenblatt et al., 1994; Tornaletti and Pfeifer, 1995) 
and p16 (Pollock et al., 1996) are frequently mutated at CpGs in tumor cells and 
30% of all inherited mutations are believed to occur by mutations at CpG sites in 
the germ line (Cooper and Youssoufian, 1988; Jones et al., 1992; Laird and 
Jaenisch, 1994).  
 
iii) Metabolism of the cofactor SAM and its involvement in carcinogenesis: 
Several studies indicate that aberration of the metabolism of the cofactor SAM 
may also play an important role in carcinogenesis (Chiang et al., 1996). 
Aberrations of the SAM metabolism may not only affect DNA methylation but also 
other methyl-transfer reactions (e.g. synthesis of spermine and spermidine). 
Insufficient supply of methionine, folate and choline leads to hypomethylation of 
liver DNA, increased expression of the c-H-ras, c-jun and c-myc genes and to the 
generation of liver tumors in rats (Simile et al., 1994; Wainfan and Poirier, 1992). 
In humans, methyldonor deficiency is correlated with an increased risk for liver 
and colon tumors (Giovannucci et al., 1993). 
 
1.2.3 DNA METHYLATION AND IMPRINTING 
 
Imprinted genes are those genes whose expression is determined by their parental origin, 
and it has been reported that cancer cells sometimes show loss of imprinting (Feinberg, 
1993) which might be explained by changes in DNA methylation that are known to 
accompany tumorigenesis. Other diseases that have been reported to be associated with 
imprinting include Prader-Willi (Nicholls et al., 1998), Angelman (Nicholls et al., 1998) and 
Rett (Willard and Hendrich, 1999) syndromes. 
Furthermore, X-inactivation in female mammals is an event associated with a methylation 
change in CpG islands. The CpG islands within the promoter regions of the X-linked 
housekeeping genes become highly methylated at or soon after gene inactivation. The 
methylation of CpG islands on inactive X-chromosome has important medical implications 
with regard to the fragile X-chromosome, and it has been found that a CpG island near to 
the breakage site is methylated in most of the affected people (Bell et al., 1991). In 
contrast to X-linked genes, the CpG islands associated with autosomal genes remain 
unmethylated, with some exceptions. These exceptions include Alu elements (Kochanek 
et al., 1993) and L1 retrotransposons (Crowther et al., 1991) which are frequently 
methylated in the human genome. Although methylation is inherently mutagenic and has 
led to genomic alterations, it is tolerated possibly because of its contribution to the 
regulation of gene expression and its  necessity during embryonic development. 
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1.3 REGULATION OF DNA METHYLATION 
 
DNA methylation patterns are known to be maintained over multiple cell generations, 
however, are not the same in different cell types. The particular patterns are established 
during early development and can change during development and disease. A model to 
explain the maintenance and change of cell specific patterns of methylation has been 
presented (Holliday and Pugh, 1975; Razin and Riggs, 1980; Riggs, 1975). A 
maintenance MTase was postulated that has a strong preference for hemimethylated 
sites and thus maintains a given methylation pattern after DNA replication. In addition, 
multiple de novo MTases were postulated, that are expressed and active at specific 
stages during development. 
 
i)  Maintenance of methylation. Replication results in the generation of a 
hemimethylated double-stranded DNA, composed of a methylated parental 
strand and unmethylated nascent strand. Only this hemimethylated DNA serves 
as a substrate for the maintenance MTase (Fig. 1.6). This model proposes that 
DNA methylation patterns are restored after replication because DNA MTase is 
very efficient in methylating hemimethylated CpG sites (maintenance 
methylation) but relatively inefficient in methylating nonmethylated substrates. 
 
ii) De novo methylation. DNA MTases can also methylate certain unmethylated 
CpG sites that are not in a hemimethylated configuration, a process referred to 
as de novo methylation (Fig.1.6). De novo methylation occurs extensively during 
gametogenesis and after implantation (Fig1.5) (Monk et al., 1987). Several 
studies have shown de novo methylated cytosines in genomic regions containing 
preexisting methylated cytosines (methylation spreading), such as it occurs at 
sites where viral DNA integrates in the genome (Doerfler et al., 1990; Riggs, 
1990; Toth et al., 1990; Turker, 1990). Since cytosine methylation can directly 
and indirectly affect the DNA binding of certain transcriptional regulatory factors 
(Fig. 1.3), the introduction of additional methylated cytosines within gene 
regulatory sequences may influence gene expression (Doerfler et al., 1990). This 
spreading of cytosine methylation in gene regulatory sequences has been 
implicated in the gene silencing characteristic of fragile X syndrome (Oberle et 
al., 1991; Pieretti et al., 1991), cellular senescence (Tollefsbol and Andrews, 
1993), and X-chromosome inactivation (Pfeifer et al., 1990). 
 
iii)  Demethylation. Demethylation may occur throughout development but is more 
pronounced during preimplantation development. Demethylation processes have 
also been shown during gene activation in resting cells (Jost and Jost, 1994). 
Two possible pathways have been described for the loss of DNA methylation: 
 
 Passive demethylation: This occurs by a failure to methylate newly replicated 
DNA (Razin and Riggs, 1980) (Fig. 1.6). This type of `demodification´ takes place 
after inactivation of cellular MTases with 5-azacytidine (Jones, 1984). 
Furthermore, it has been shown that a correlation exists between the overall 
decrease in the genomic methylation level and the active retention of Dnmt1 in 
the cytoplasm from the oocyte to the blastocyst stage (Cardoso and Leonhardt, 
1999; Carlson et al., 1992). 
 
Introduction 
 
 10
Active demethylation: It has been shown that methyl groups are removed when 
DNA is not even undergoing replication, such as that seen on inducing the 
vitellogenin gene in the chick liver (Wilks et al., 1984) or the globin gene in 
stimulated erythroleukemia cells (Razin et al., 1986). Active demethylation has 
been described in transiently transfected myoblasts (Paroush et al., 1990), in 
postmeiotic spermatocytes (Trasler et al., 1990) and in preimplantation mouse 
embryos (Kafri et al., 1993). This active process of demethylation could involve 
5mC DNA glycosylase activity which has been detected in HeLa nuclear extracts 
(Vairapandi and Duker, 1993). Other studies have also shown that the 
demethylation process is at least partly mediated by RNA molecules and that 
demethylation takes place through the removal of DNA nucleotides and their 
conversion to an RNase-sensitive form (Weiss et al., 1996). Recently, a human 
cDNA that encodes a DNA demethylase (dMTase) activity that can catalyze the 
removal of a methyl residue from 5mC and its release as methanol has been 
cloned (Bhattacharya et al., 1999).  
 
 
Fig.1.6. Establishment and maintenance of DNA methylation patterns.  The 
establishment of DNA methylation patterns involves a number of processes. Left, de novo 
methylation: when a potential methylatable site (indicated as a circle) that is not 
methylated on both strands of the DNA undergoes methylation (indicated as M outside 
the circles). Center, maintenance methylation: the DNA molecule is composed of a 
parental methylated strand (thick line) and a nascent unmethylated strand (thin line). 
Maintenance DNA MTases add methyl groups to the nascent unmethylated cytosines 
that reside opposite to methylated sites on the parental strand and thus the pattern of 
methylation is replicated. Right, demethylation: when a methyl group (M) is removed from 
methylated CpG sites. 
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1.4 MAMMALIAN DNA MTases 
 
The first mammalian DNA MTase reported was the Dnmt1. The Dnmt1 cDNA from 
mouse has been cloned and its nucleotide sequence determined (Bestor, 1988; Tucker et 
al., 1996; Yoder et al., 1996). Partial loss of function mutation of the Dnmt1 gene results 
in embryonic lethality showing that Dnmt1 is essential for mouse development (Li et al., 
1992). Dnmt1 contains a C-terminal (570 amino acids) domain joined to a much larger N-
terminal (1051 amino acids) domain by a region of 13 alternating Gly and Lys residues; 
this region is encoded in the cDNA by 39 consecutive purine residues. This hydrophilic 
sequence is likely to form a flexible link between the N- and C-terminal domains. The C-
terminal domain contains ten motifs (I-X) which are also present in most prokaryotes 5mC 
MTases. Motif I (PheXGlyXGly) was proposed to be part of the cofactor (SAM) binding 
site. This assignment was based on the presence of this consensus sequence in a wide 
variety of SAM dependent MTases, including N6-adenine, N4-cytosine, RNA and protein 
MTases (Ingrosso et al., 1989; Klimasauskas et al., 1989). Motif IV contains a dipeptide 
(ProCys) known to take part in the catalytic reaction. In the bacterial MTase HhaI this 
reaction involves the formation of a covalent intermediate between the cysteine from 
motif IV and the target cytosine (see section 1.1.2). The region between motifs VIII 
(GlnXArgXArg) and IX (ArgGlu) contains the target recognition domain (TRD) which 
determines the DNA sequence specificity (Klimasauskas et al., 1991) as well as the base 
to be methylated within the target sequence (Mi and Roberts, 1992). Several functions 
have also been localized to the N-terminal domain. The N-terminal domain contains a 
cysteine-rich region that is similar to metal-binding sites found in several regulatory 
proteins and it was shown to bind Zn (Bestor, 1992). The location of some of the relevant 
features in Dnmt1 are shown in Fig.1.7. 
 
 
Fig.1.7. Structure of the mouse Dnmt1 protein. The Dnmt1 protein contains an N-
terminal domain of 1051 amino-acids which is joined to the 570 amino-acid C-terminal 
domain by a run of 13 alternating lysyl and glycyl residues, shown in the figure as a thick 
connecting line. Binding site for PCNA: proliferating cell nuclear antigen (Chuang et al., 
1997); NLS: nuclear localization sequence (Cardoso and Leonhardt, 1999; Leonhardt et 
al., 1992); Ser: phosphorylation site at serine 514 (Glickman et al., 1997); RFTS: 
replication foci targeting sequence (Leonhardt et al., 1992); Zn binding: in vitro zinc 
binding (Cys-rich) region (Bestor, 1992); PBHD: polybromo-1 protein homologous domain 
(Liu et al., 1998); ProCys: dipeptide part of the catalytic site (Cheng et al., 1993; Wu and 
Santi, 1987); TRD: target recognition domain (Trautner et al., 1988); filled boxes: highly 
conserved sequence motifs (I, II, IV, V, VI, VII, IX, X); grey boxes: less conserved 
sequence motifs (III, V, VII) between the mammalian and the bacterial MTases.  
 
A major phosphorylation site of the Dnmt1 has been reported (Glickman et al., 1997), 
indicating that the murine Dnmt1 is posttranslationally modified. The site lies in a region 
of the protein that is required for targeting of the MTase to the replication foci during S 
phase of the cell cycle (Leonhardt et al., 1992). Furthermore, it has been proposed that 
several factors might be involved in maintaining the methylation patterns in the 
Introduction 
 
 12
mammalian genome by interacting with Dnmt1. It has been reported that Dnmt1 binds to 
the proliferating cell nuclear antigen (PCNA) in vitro (Chuang et al., 1997) and this could 
mediate the association of Dnmt1 with the DNA replication machinery in vivo.  
Proteolytic cleavage between the N- and C-terminal domains stimulates the de novo 
methylation activity of the murine Dnmt1 (Bestor, 1992) in vitro, suggesting that this 
enzyme may also be responsible for de novo methylation occurring in vivo. This was 
proposed to be the consequence of separation of the catalytic domain from the inhibitory 
N-terminal domain. This complex structure of Dnmt1 raises the possibility that Dnmt1 
might carry out both, maintenance and de novo, methylation and these activities might be 
controlled by the expression of alternative isoforms or by posttranslational modification of 
the enzyme. Another alternative but not mutually exclusive possibility is that an 
independently encoded and developmentally regulated DNA MTase is responsible for de 
novo methylation. A null allele of the Dnmt1 gene (Lei et al., 1996) showed that 
embryonic stem (ES) cells homozygous for the null mutation still had very low levels of 
genomic DNA methylation. Infection of mutant ES cells with the Moloney murine 
leukaemia virus (MoMuLV) resulted in de novo methylation of the integrated provirus 
DNA with a similar rate to that seen in wild type ES cells, suggesting that de novo 
methylation is not totally impaired by loss of Dnmt1. These results provide evidence that 
an independently encoded DNA MTase is expressed in early embryonic cells. Recently 
three additional mammalian MTases genes were cloned, Dnmt2 (Okano et al., 1998; Van 
den Wyngaert et al., 1998; Yoder and Bestor, 1998), Dnmt3a and Dnmt3b  (Okano et al., 
1998). Dnmt3a and Dnmt3b are essential for de novo methylation and for mouse 
development and Dnmt3b is required for methylation of centromeric minor satellite 
repeats (Okano et al., 1999). However, the expression of Dnmt3a and Dnmt3b has not 
yet been characterized. 
Evidence for the presence in some tissues of alternative Dnmt1 isoforms first came from 
the identification of a transcript longer than the one present in somatic cells during 
spermatogenesis (Trasler et al., 1992). This longer transcript could be due to additional 
sequences at the 5’ end of the Dnmt1 gene or to new alternatively spliced Dnmt1 
isoforms. Thus, different Dnmt1 isoforms with different enzymatic properties might be 
expressed in specific tissues at particular stages and might play a role in the regulation of 
methylation during gametogenesis and tissue differentiation. The focus of this study was, 
therefore, to search for alternative Dnmt1 isoforms and to study their expression during 
development, as well as to try to elucidate the Dnmt1 exon-intron boundaries and its 
relation with the protein structure. 
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The purpose of this section is to describe the principles and practical details of the 
techniques used in this study. Specific details of the methods used are described in the 
respective results section. 
 
2.1 RNA ISOLATION 
 
Total RNA extracted from mouse organs (strain C57Bl6) and cultured muscle cells 
(C2C12) was used as a template in RT reactions. The animals were killed by cervical 
dislocation and the organs were immediately taken, rinsed briefly in PBS and either 
frozen in liquid nitrogen or in isopentane precooled in liquid nitrogen depending on the 
subsequent applications, respectively RT or in situ hybridization.  
During the RNA work a series of precautions were taken to avoid RNase contamination. 
Glassware was baked at 200oC for at least 4 hours and water was treated with  DMPC 
(Dimethylpyrocarbonate). A 10% DMPC stock was prepared in ethanol, which was then 
diluted 1:100 in double distilled water, left at room temperature overnight and finally  
autoclaved.  
Total RNA extractions were done with a Qiagen kit (RNeasy) following the instructions of 
the manufacturer. The purity  of total RNA was checked by running ~ 1ml of total RNA on 
a 1% agarose gel made in TAE buffer (0.04 M Tris-acetate/ 0.001 M EDTA pH 8) with 0.5 
mg/ml ethidium bromide. The two ribosomal RNA bands (23S and 18S) were clearly 
detected when the gel was viewed under ultraviolet light (UV) and smears (as indicator of 
RNA degradation) were not seen between the two bands. To quantify the total RNA an 
aliquot was measured by UV absorbance at 260 nm (A260) and 280 nm (A280) where the 
absorbance of 1 in a 1 cm path length corresponds to a RNA concentration of 40 mg/ml. 
The absorbance ratio of 260 nm and 280 nm gave an estimate of the purity of the 
solution. Pure RNA solutions had  A260/A280 values between 1.7-2. 
 
2.2 REVERSE TRANSCRIPTION 
 
To assay for Dnmt1 gene expression, total RNA from mouse tissues and cells was 
reverse transcribed into cDNA. For this reaction hexamer primers of random sequence as 
well as oligonucleotides of defined sequence were used. Random hexamers are used 
when a particular mRNA is difficult to copy in its entirety, because of the presence of 
sequences that cause the RT to stop synthesis. With this method, all RNAs in a 
population serve as templates for first-strand cDNA synthesis. Most specific is to use an 
oligonucleotide containing sequence information that is complementary to the desired 
target RNA. The advantage of using a specific primer is that only the desired cDNA is 
produced, facilitating the subsequent PCR amplification. The following components were 
mixed in a total volume of 20 ml to perform a reverse transcription reaction: 1 mg of total 
RNA  was mixed  with 1 x reaction buffer  (100 mM Tris/ 500 mM KCl pH 8.3), 5 mM 
MgCl2,  2-10 pmol of primer, 1 mM each dNTP and 20 units of avian myeloblastosis virus 
(AMV) reverse transcriptase enzyme (Roche Molecular Biochemicals). The mixture was 
then briefly vortexed and incubated at 25oC for 10 min to allow the primer to anneal to the 
RNA, followed by incubation at 42oC for 1 h during which the RNA was reverse 
transcribed resulting in cDNA synthesis. The AMV enzyme was then denatured by 
incubating the reaction at 99oC for 5 min and then the mixture was cooled down to 4oC for 
5 min. 
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2.3 POLYMERASE CHAIN REACTION 
 
PCR was used to amplify  segments of DNA that were between two regions of known 
sequence using either genomic or cDNA as a template. Genomic DNA was prepared 
from mouse embryos as follows: i) the sample of interest was cut into small pieces using 
a blade and making sure that the sample stayed frozen at all times by keeping it in liquid 
nitrogen; ii) the pieces of sample were placed in an eppendorf tube and 850 ml of buffer 
(10 mM Tris pH 8.5/ 5 mM EDTA pH 8/ 0.2% SDS/ 200 mM NaCl) were added containing 
proteinase K at a final concentration of 150 mg/ml; iii) the tubes were placed at 50oC for 5 
h or at 37oC overnight in a shaking water bath and from time to time the samples  were  
vortexed to disrupt  the tissue; iv) the samples were  then  heated  at 95oC for 10 min. 
For the PCR reactions , either 5 ml from the RT product (~0.25 mg of cDNA) or 100 ng 
genomic  DNA  were  used in  a  total volume  of 50 ml  containing 1 x PCR buffer (100 
mM Tris/ 50 mM MgCl2/ 500 mM KCl pH 8.3), 0.2 mM each dNTP, 15 pmol from each 
primer and 5 units of Taq polymerase. Different Taq enzymes were used depending on 
the size of the fragment expected: for up to 2000 bp, the Taq polymerase was used; for 
bigger fragments, the Long Expand PCR kit (Roche Molecular Biochemicals), which 
contains a mixture of a thermostable Taq and Pwo DNA polymerases with a 3’ to 5’ 
proofreading activity, was used. For the amplification of cDNA, oligos located in cDNA 
areas spanning intron locations were used to control for possible genomic DNA 
contamination. 
The PCR mixtures containing all the necessary reagents were denatured by heating at 
94oC, then cooled to a temperature which allows the oligonucleotide primers to anneal to 
their target sequences (usually 5oC less than the primer’s melting temperature), finally the 
annealed primers were extended with DNA polymerase. The cycle of denaturation, 
annealing and DNA synthesis was repeated for ~ 30 cycles, so that the products of one 
round of amplification served as templates for the next, doubling the amount of desired 
DNA product in each round. The reactions were carried out on a DNA Thermal Cycler 
(Biometra) and when optimization of annealing temperatures was necessary the 
Mastercycler Gradient (Eppendorf) was used. The latter allows the use of a gradient 
function which enables changes of temperature between 4oC and 99oC to be tested 
simultaneously. 
The amplified DNA fragment was separated by gel electrophoresis on a 1% agarose gel 
in TAE buffer containing 0.5 mg/ml ethidium bromide. The fluorescence from the DNA 
bands with the intercalating dye was visualized by exposing the gel to UV light. 
Depending upon the expected size, the following DNA molecular weight markers were 
used: SmartLadder (Eurogentec), 100 bp Ladder, Lambda DNA cut with BstEII or 
Lambda DNA cut with Hind III (all from New England BioLabs). Comparison of the 
fluorescence intensity of the PCR fragments with the standard bands from the molecular 
weight marker provided, in addition, an estimation of the amount of DNA in the samples.  
Fresh PCR products of the desired size were gel purified with Qiaex II (Qiagen). The gel 
purification method is based in the adsorption of DNA molecules to silica particles in the 
presence of high salt. After washing away the non-nucleic acid impurities, the DNA was 
eluted in ~ 20 ml of 10 mM Tris-HCl pH 8.5. Fresh PCR products were also directly ligated 
into the appropriate vector depending on the subsequent applications (pCRII vector for 
sequencing or in vitro transcription, pCR3.1 vector for protein expression in mammalian 
cells, both vectors are from Invitrogen).  
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2.4 PLASMID DNA TRANSFORMATION INTO 
ESCHERICHIA COLI AND SELECTION OF 
RECOMBINANTS 
 
The plasmid DNA was transferred into bacteria by a process known as transformation, in 
which the plasmid is taken up by bacteria that had been pretreated to make some of the 
cells temporary permeable to small DNA molecules, i.e., competent (Dagert and Ehrlich, 
1979; Mandel and Higa, 1970). The new phenotype conferred by the plasmid (i.e., 
resistance to an antibiotic) allows selection of bacteria that had been successfully 
transformed. After transformation, the Escherichia coli cells were plated on Luria Bertani 
(LB) medium  with the appropiate antibiotic and incubated overnight at 37oC. The next 
day, isolated bacterial colonies were checked either by PCR using oligos located in the 
vector and insert or by small scale plasmid DNA isolation using the alkaline lysis method 
(Birnboim and Doly, 1979) and subsequent restriction enzyme analysis. Briefly, bacteria 
were lysed by treatment with a solution containing SDS (denatures bacterial proteins) and 
NaOH (denatures chromosomal and plasmid DNA). The mixture was neutralized with 
potassium acetate, causing the plasmid DNA to reanneal rapidly. Most of the 
chromosomal DNA and bacterial proteins precipitated, as well as the SDS which formed 
a complex with potassium, and were removed by centrifugation. The reannealed plasmid 
DNA was then concentrated by ethanol precipitation. Restriction enzyme and/or PCR 
analyses of the plasmid DNA allowed identification of the plasmids containing the right 
insert, i.e., of the correct recombinants. Selected recombinant bacteria were grown in 
large scale and subsequent isolation of plasmid DNA was carried out with the Plasmid 
Maxi kit following the instructions of the manufacturer (Qiagen). Briefly, this method is 
based on a modified alkaline lysis procedure, followed by binding of plasmid DNA to an  
anion-exchange resin under appropriate low salt and pH conditions. RNA, proteins and 
low molecular weight impurities were removed by a medium salt wash. Plasmid DNA was 
eluted in a high salt buffer, concentrated and desalted by isopropanol precipitation.   
 
2.5 SEQUENCING 
 
Plasmids were sequenced to verify that they contained the desired inserts and to control 
for unwanted mutations. Samples were processed by the dye terminator method (Applied 
Biosystems) and purified from unintercalated labeled dNTPs by Centri-Sep spin columns 
(Applied Biosystems). The samples were then mixed with 4 ml buffer (deionized 
formamide and 25 mM EDTA pH 8 containing 50 mg/ml Blue dextran in a ratio 5:1 
formamide:EDTA-Blue dextran), denatured by heating at 94oC for 4 min, and loaded onto 
a sequencing gel on an automated DNA sequencer (Applied Biosystems). This 
sequencing method is based on the dideoxy method developed by Sanger (Sanger et al., 
1977). Briefly, this technique involves the synthesis of a DNA strand from a single-
stranded template by DNA polymerase and depends on the fact that dideoxynucleotides 
(ddNTPs) are incorporated into the growing strand in the same way as the conventional 
deoxynucleotides (dNTPs). However, ddNTPs differ from dNTPs because they lack the 
3’-OH group necessary for chain elongation. With the dye terminator only molecules that 
have terminated are labeled, and the four base-specific terminations are carried out in the 
same tube and then analyzed in the same lane of a gel. The latter is possible because a 
different fluorescent dye is attached to each nucleotide and incorporated into the DNA 
chain during the copying reaction catalyzed by DNA polymerase. The samples were then 
separated on a polyacrylamide gel and the fluorescent nucleotides excited with a laser 
beam. The emitted fluorescence was collected by detectors and sent to a computer, 
where the appropriate software converted the data into nucleotide sequence. For 
Materials and Methods 
 
 16
sequence assembling, editing and alignments, the Lasergene software programs Edit 
Seq, SeqMan and MegAlign (DNASTAR, Madison) were used. Some samples were  
sequenced by the companies GATC or MWG. 
 
2.6 NORTHERN HYBRIDIZATION 
 
This technique was used to study the number, size and levels of Dnmt1 transcripts in 
different tissues and it is based on the hybridization of a labeled nucleic acid probe (RNA 
or DNA) to a complementary sequence of mRNA.  
 
2.6.1 PROBE LABELING 
 
cDNA fragments subcloned into pCRII vectors were prepared by restriction digestion of 
plasmids and isolated by gel purification. For radioactive labeling of DNA fragments the 
random primer extension method (Amersham) was used and the enzyme required for this 
process was Escherichia coli DNA polymerase I (Klenow fragment). The procedure relies 
on the ability of random oligonucleotides to anneal at multiple sites along the length of a 
DNA template. Starting from these oligonucleotides annealed to the DNA, the DNA 
polymerase I synthesizes new complementary strands incorporating labeled dNTPs 
present in the reaction mixture.  
The reaction mixture contained: 25 ng of DNA (which have been previously gel purified) 
and 5 ml of random nonamer primers (Amersham), which were brought to 50 ml final 
reaction volume with double distilled water. This initial mixture was denatured by boiling 
for 5 min. Keeping the tube at room temperature, the unlabeled dNTPs (0.1 mM each, 
omitting those to be used as label) and reaction buffer (from Amersham, containing Tris-
HCl pH 7.5, 2-mercaptoethanol and MgCl2) followed by the radiolabeled dNTPs and DNA 
polymerase I (Klenow fragment) enzyme (0.04 units/ml) were added. The reaction was 
then incubated at 37oC for 1 h. Phosphorus-labeled dNTPs (3000 Ci/mmol [a-32P] dCTP 
and 3000 Ci/mmol [a-32P] dATP) were used. Non incorporated labeled nucleotides were 
removed from the probe by precipitation with 0.1 volume of 4 M LiCl and 2.5 volumes of 
chilled absolute ethanol and incubation at –70oC for 30 min and centrifugation at  13000 g  
for 15  min at  4oC. The  pellet was then  washed with ~ 100 ml of cold 70% ethanol, air 
dried and dissolved in 20 ml of double distilled water. The efficiency of the labeling 
reaction was monitored by a scintillation counter (Beckman).  
 
2.6.2 HYBRIDIZATION 
 
Hybridization and washing conditions varied depending on the stringency required to 
obtain the highest signal and the lowest background. The hybridization solution is one of 
the critical parameters to consider and should contain blocking reagents such as herring 
sperm DNA, as blocking reagent, to prevent nonspecific binding of RNA probes to the 
blotting membrane. The hybridization temperature also needs to be optimized to ensure 
optimal hybridization to the target and minimal nonspecific binding of the probe. The final, 
stringent wash is usually 10oC below or in some cases the same as the hybridization 
temperature. The buffer used was from Clontech or according to Church et al. (Church 
and Gilbert, 1984) (7% SDS/ 1% BSA/ 0.25 M NaHPO4 pH 7.2/ 1 mM EDTA pH 8). 
Prehybridization which contained only the hybridization buffer (5 ml) without the labeled 
Materials and Methods 
 
 17
probe was done for 4 h and hybridization overnight, containing 5 ml hybridization buffer 
and  2 x 106 cpm/ml labeled probe. The probe and 50 mg/ ml of herring sperm DNA were 
denatured  by boiling for 5 min before adding to the blots. The temperature for pre- and 
hybridization was 68oC. After hybridization the blots were washed twice 20 min with 0.1x 
SSC, 0.1% SDS at 50oC with continuous shaking. The blot was retrieved from the 
hybridization bottles and the excess of wash solution was removed not allowing the 
membrane to dry. The blot was covered with plastic wrap and exposed to a 
phosphorimager screen (Molecular Dynamics) for 24 h to one week. The signals were 
detected by scanning the screens on a phosphorimager using the Image Quant software 
(Molecular Dynamics). The probe was removed from the blot by incubating for 10 min in 
boiling distilled water. This process was repeated three times and the water allowed to 
cool for 10 min before the blot was stored in plastic wrap at –20oC, until needed for new 
hybridization experiments. 
 
2.7 IN SITU HYBRIDIZATION 
 
The principle of in situ hybridization is very similar to Northern hybridization and is based 
on the annealing of a labeled nucleic acid probe (RNA or DNA) to a complementary 
sequence of mRNA. The two techniques differ in that the starting material for a Northern 
is a tissue extract, whereas the primary material for in situ hybridization is a histological 
tissue section. The relative cell position in the tissue is lost with Northern blots and mRNA 
levels are averaged from all the cells contained in the original sample. However, in situ 
hybridization can detect amounts of mRNA contained in a single cell. Furthermore, since 
in situ hybridization is a histological technique, tissue structure is preserved and it is 
possible to precisely identify the cell type expressing the gene of interest. A major 
advantage of in situ hybridization is that it allows the maximal use of tissues that may be 
in short supply while an organ extract might yield sufficient RNA for one or two Northern 
blots only. These Northern blots are useful to quantify specific mRNAs, but large amounts 
of tissue extracts are required. Although Northern blots can be probed multiple times for 
different mRNAs, in fact this is limited to four or five different probes at most, since 
repeated stripping of the blots leads to RNA loss from the membranes. In situ 
hybridization is a semi-quantitative technique but provides information concerning the 
cellular source of the RNA.  
There are many different ways to do in situ hybridization and it can be done with 
radioactive or non-radioactive probes. The use of 35S labeled riboprobes to hybridize 
frozen tissue sections has been proven to be the most sensitive method (Wilcox, 1993). 
32P labeled probes used for Northern blots are not suitable for the in situ technique due to 
the high energy produced by 32P, which does not allow the detailed cellular resolution of 
the signal. To control for genomic DNA hybridization and unspecific binding, concurrently 
with the slides containing the antisense probe, adjacent tissue sections were also 
included containing a control sense RNA probe. 
 
2.7.1 PROBE LABELLING 
 
For riboprobe preparation 1 mg of plasmid DNA containing T7, SP6 or T3 RNA 
polymerase binding sites was linearized by digestion with a restriction enzyme 
downstream (antisense probe) or upstream of the insert sequence (control sense probe). 
The linearized DNA template was then purified by two phenol extractions 
(Phenol/Chloroform/Isoamylalcohol: 25/24/1) and LiCl/ethanol precipitation. The DNA 
was transcribed at 37oC in 20 ml total volume for 2 h with 2 ml 1x transcription buffer 
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(Promega) (200 mM Tris-HCl pH 7.5/ 30 mM MgCl2/ 10 mM spermidine/ 50mM NaCl), 2 
ml 10mM GTP/ATP, 2.5 ml each a-35S CTP (800 Ci/mmol), a-35S UTP (800 Ci/mmol) and 
1 ml of the appropriate RNA polymerase enzyme (20 units). The labeled probe was 
recovered by LiCl/ethanol precipitation and washed with ethanol as described in 
preparation of probes for Northern hybridization (section 2.6.1). A sense probe, was also 
labeled as a negative control.  
Long probes penetrate less effectively into fixed tissue and the magnitude of this effect 
depends on the tissue preparation and type of probe used. To increase penetration of the 
probe in the tissue, long fragments used as RNA probes (~ 1000 nucleotides) were 
reduced to an average of 150 to 200 nucleotides by alkaline hydrolysis. The alkaline 
hydrolysis was carried out by dissolving the probe in 50 ml of DMPC treated water and the 
pH adjusted to 10.2 by addition of 30 ml of 0.2 M Na2CO3 and 20 ml of 0.2 M NaHCO3 and 
incubated at 60oC for 30 min. The hydrolysis was stopped by addition of 3 ml of 3 M 
sodium acetate pH 6 and 5 ml of 10% glacial acetic acid. The hydrolyzed probe was 
precipitated with ethanol and resuspended in a small volume of DMPC water.  
 
2.7.2 SAMPLE PREPARATION 
 
Tissue sectioning 
Handling of glass, reagents and the extraction of organs from the animal was as in 
section 2.1. If the tissue was dense and compact (e.g. muscle), the specimen was frozen 
in isopentane precooled in liquid nitrogen. Isopentane shortened the time needed for 
freezing. Fragile tissues were placed in a plastic capsule containing a freezing agent 
(Tissue Tek), before being frozen. Frozen tissues were sectioned with a cryotome 
(Microm) into 6-12 mm thick slices, thaw-mounted at 42oC on coated slides 
(Superfrost/Plus, Fisher Scientific) and immediately re-frozen by placing the slides in the 
plastic slide boxes kept in the cryostat or on dry-ice and stored at –70oC until use. The 
frozen tissue slides were first left at room temperature for 1 h to thaw before tissue 
sectioning.   
 
Fixation 
Unlike blotting membranes, tissues are not chemically uniform and respond differently to 
fixation protocols. Procedures that preserve good morphology and retain RNA usually do 
not give high hybridization efficiency. Extensive fixation preserves histological detail and 
prevents loss of target RNA during hybridization and wash procedures. However, milder 
fixation increases accessibility of the hybridization probes to the RNA target (and to any 
other molecules such as antibodies) and reduces the possibility of chemical modification 
of the target RNA and concomitant loss of hybridization. Thus it is important to optimize 
fixation and prehybridization treatments of tissue to find the best compromise between 
these requirements. Cross-linking fixatives were favored because they provided much 
better retention of cellular RNA and help to inactivate nucleases in tissues.  
The frozen tissue sections were fixed for 20 min in 4% paraformaldehyde (8 g of 
paraformaldehyde were dissolved in  200 ml PBS by adding 1-2 pellets of NaOH, the pH 
was then adjusted to 7 with HCl). The sections were then washed three times 3 min  in 
PBS.  
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Acetylation  
The purpose of this step was to cover the section with negative charges to repel nucleic 
acids and thus reduce electrostatic binding of the probe to the section. The tissue slides 
were incubated for 10 min in the acetic anhydride solution (250 ml distilled water/ 3.1 ml 
Triethanolamine/ 675 ml acetic anhydride). After the incubation period the slides were 
washed 3 min in PBS.  
 
Dehydration  
The sections were dehydrated by passing the slides through an ascending ethanol series 
(50%, 70%, 90%, 96%) and were then left to dry at room temperature for 2-3 h. 
 
2.7.3 HYBRIDIZATION 
 
The slides were placed in a box with a piece of filter paper saturated with buffer (4 x 
PBS/50% formamide) during the prehybridization and hybridization steps. The 
prehybridization step was carried out by covering each slide with 100 ml of hybridization 
buffer (50% deionized formamide/ 10 mM Tris-HCl pH 7.5/ 5 mM EDTA pH 8/ 2 x SSC/ 
150 mg/ml herring sperm DNA/ 150 mg/ml yeast  tRNA/ 10% dextran  sulfate/ 1 x 
Denhardt´s solution/ 0.1 mM UTP/0.1 mM CTP) without probe and incubating at 37oC for 
4 h. Hybridization was performed with a mixture containing the hybridization buffer and 
the 35S-labeled riboprobe (108 cpm/ml). This mixture was heated at 95oC for 10 min and 
placed on ice. DTT was then added at a final concentration of 0.1 M. The probe mixture 
was vortexed and 10 ml was added to the sections. Siliconized coverslips were placed on 
top of each sample and incubation was done overnight at 42oC. The coverslips were 
removed from the sections by soaking the slides in 1x SSC. 
 
After hybridization the sections were washed 20 min at 60oC in 5 x SSC/ 1 mM DTT, 30 
min at 60 oC in 2 x SSC / 50% formamide/ 1mM DTT, 2 x 10 min at 37oC in RNase-buffer  
(10 mM Tris-HCl pH 8/ 1mM EDTA pH 8/ 0.5 M NaCl), 30 min at 37oC RNaseA digest (10 
mg/200 ml) to remove nonspecifically bound single-stranded RNA probe, thus reducing 
the background signal in autoradiographs , 10 min at 37oC in RNase buffer, 1h at 60oC in 
2 x SSC, 10 min at 60oC in 0.1 x SSC.  
 
The slides were dehydrated by dipping them for a few minutes in an ascending ethanol 
series and were left to dry at room temperature. The slides were exposed to a 
Phosphorimager screen to produce a fast low resolution image or dipped in photographic 
emulsion for high cellular resolution images. The latter involved dipping of slides into a 
nuclear track emulsion (Amersham), whereby the sections are covered with a thin layer of 
the emulsion (silver bromide crystals in gelatin). The emulsion was first melted at 42oC 
and after dipping the slides in it, these were left to dry at room temperature for 1 h and 
then exposed in the dark at 4oC. Exposure times varied from 1 to 4 weeks depending on 
the probe and sample. To avoid artifacts, the slides were allowed to warm up to room 
temperature before photographic development. Decay of radionucleotides leads to the 
formation of latent images in the emulsion layer. Latent images were converted into real 
images by photographic development (Kodak) and fixation (Kodak). The slides were then 
counterstained with hematoxylin (Sigma).  
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2.8 CELL CULTURE AND TRANSFECTION 
 
The cells used were mouse C2C12 myoblasts (Yaffe and Saxel, 1977) and COS-7 cells 
(African green monkey kidney fibroblast-like cells transformed with SV40T antigen; 
(Gluzman, 1981)). The C2C12 cells were used because they are a well characterized 
tissue culture skeletal muscle differentiation system to screen for Dnmt1 isoforms during 
myogenesis. These cells were studied at different stages of growth and differentiation 
(see Results section). The COS-7 cells were used to test the translation efficiency of 
Dnmt1 isoforms by immunofluorescence and Western blot analyses (see Results 
section). 
Both types of cells were grown in a humidified atmosphere of 5% CO2 and at a 
temperature of 37oC. The cells were maintained at subconfluent densities in growth 
medium containing Dulbecco´s modified Eagle´s medium (DMEM) with 10% and 20%  
fetal bovine serum (FBS) for COS and C2C12 cells respectively,  and were split every 48-
72 h. Proteolytic enzymes such as trypsin in combination with EDTA were used to detach 
the cells from the growth surface to harvest or to subculture them. Frozen cells were 
thawed by placing the vials in a 37oC water bath by gently agitating the vial, cell 
suspension was then pipetted into a plate containing pre-warmed growth medium. For 
long term storage cells were harvested as above and washed once with complete 
medium. The cells were then resuspended in complete medium and counted. The cells 
were stored in complete medium with 10% DMSO and aliquots of cells (about 106 
cells/ml/cryovial) were frozen and kept in liquid nitrogen. C2C12 cells were transferred to 
DMEM with 5% horse serum (differentiation media) whenever differentiation was needed. 
Transient transfections were done with the corresponding eukaryotic expression plasmid 
in COS-7 cells by the lipofection method (GenePorter), following the instructions of the 
manufacturer (Gene Therapy Systems, Inc.). Seventy two hours after transfection, cells 
were washed twice with PBS and either fixed with 3.7% formaldehyde in phosphate 
buffered saline and  immunostained or pelleted for subsequent cell extract preparation 
and Western blot analysis. 
 
2.9 IMMUNOFLUORESCENCE ANALYSIS  
 
2.9.1 TISSUE SECTIONS 
 
Organs were collected from the animal as in section 2.1 and fixed overnight with Serra’s 
(60% absolute ethanol/ 30% formaldehyde/ 10% glacial acetic acid) or Carnoy’s solution 
(60% absolute ethanol/ 30% chloroform/ 10% glacial acetic acid). Both have proven to 
give equally good results. The next day the organs were embedded in paraffin with a 
Techno-Tec1 automat (Pathotec).  
The sectioning of paraffin embedded material was done with a rotary microtome 
(Microm). After each cut the section was floated on a thermostatically controlled water 
bath (40-45oC). Then a slide was dipped under the section and upon lifting the section 
adhered to the slide. The slides were then left to dry on a warming plate.   
Sections were deparaffinized by incubating at 60oC for 1 hour, then in Xylol for 15 min, in 
isopropanol for 5 min, in a descendent ethanol series (96%, 70%, 50%) 5 min each and 
finally in PBS for 5 min. The samples were then placed in 0.01 M citrate buffer pH 6 and 
autoclaved for 20 min at 94oC. 
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2.9.2 CULTURED CELLS 
 
Cells were treated were treated with 3.7% formaldehyde in PBS for 10 min which leads to 
the formation of chemical cross links  between free amino groups. Fixation with 
formaldehyde does not allow access of the antibody to the specimen and therefore was 
followed by a permeabilization step using a nonionic detergent. After fixation the 
coverslips were washed twice with PBS. Permeabilization of the fixed cells was 
performed by incubation in 0.2% Triton X-100 in PBS for 5 min at room temperature. The 
cells were finally rinsed and kept in PBS.   
 
2.9.3 IMMUNOSTAINING 
 
Fixed samples (tissues or cells) were blocked for 30 min with 0.2% fish skin gelatin. After 
fixation, incubation with the first antibody (Ab) for 2 hours was done. The unbound 
antibody was removed by three 10 min washes with PBS-Tween-20 (0.2%). The 
secondary fluorescently conjugated Ab was then added and incubated for 1 h. After 
washing as before, nuclear DNA was stained for 5 min with Hoechst 33258 at a 
concentration of 1 mg/ml. Finally, samples were washed again and mounted in Mowiol, 
which hardens within a few hours forming a permanent preparation.  
Secondary antibodies with different fluorochromes (fluorescein or rhodamine) were used. 
Under the appropriate illumination, fluorochromes are excitated alllowing the localization 
of the antibodies and, through them, the distribution of the antigen under study. The 
methods used are indirect detection and relied on a labeled secondary antibody that 
recognizes specifically the unlabeled primary antibody.  
Protein expression and subcellular localization was also analyzed by epitope tagging. The 
tag itself is a small open reading frame, and fusion of tags with the protein under study was 
achieved by standard molecular biology methods. The epitope tag is a short amino acid 
sequence, that is placed within the coding region of the target protein to specify the binding 
site for a known monoclonal or polyclonal antibody. The tagged target protein can then 
easily be detected using well characterized antibodies directed to the tag. Tagged proteins 
were then produced in COS-7 cells using an appropriate expression vector (pCR3.1 from 
Invitrogen). The expression and localization of tagged proteins were monitored in 
transfected COS-7 cells. The Flag tag is not derived from any known protein and contains 
an 8-amino acid peptide (Asp, Tyr, Lys, Asp, Asp, Asp, Asp, Lys) that is hydrophilic and 
can be placed at both the amino and carboxyl termini of the target protein. There are two 
commercially available antibodies, M1 and M2, that recognize the Flag tag. The M1 
antibody requires the amino terminus of the epitope to be available, thus the tag is placed 
at the amino terminus of the protein. The M2 antibody was the one used, which recognizes 
the same Flag epitope when placed internally within a protein or at the carboxyl terminus.  
 
2.10 MICROSCOPY 
 
Immunofluorescence samples were examined and photographed on a Zeiss Axioplan 2 
microscope equipped with phase-contrast and epifluorescence optics, using 63x Plan-
Apochromat, 2.5x, 20x, 40x Plan-Neofluar and 4x Achroplan objectives.  
A Zeiss AxioLab microscope equipped with phase-contrast and darkfield condenser, was 
used to examine in situ hybridization specimens using 4x, 10x, 20x and 40x Achroplan 
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and 2.5x Plan-Neofluar objectives.  
Images were taken with CCD cameras (SensiCam, PCO and ProgRes, Kontron 
Elektronik) using Zeiss Axiovision and Photoshop software. 
 
2.11 CELL EXTRACTS AND WESTERN BLOT ANALYSIS 
 
Transfected cells were harvested by centrifugation at 13,000 x rpm for 5 min and cell 
pellets were resuspended in ice-cold RIPA buffer (500 mM Tris-HCl pH 8/ 150 mM NaCl/ 
1% NP-40/ 0.5% DOC/ 0.1% SDS) with protease inhibitors (leupeptin, aprotinin, 
pepstatin). The cell suspension was incubated on ice for 5 min and extracted proteins 
were recovered from the supernatant after centrifugation at 13000 x rpm for 5 min. The 
protein extracts were denatured by boiling in Laemmli sample buffer (2% SDS/ 20% 
glycerol/ 250 mM Tris-HCl pH 6.8/ 10% b-mercaptoethanol/ 0.1% bromophenol blue) 
prior to loading onto a gel. Proteins were separated on a 10-20% gradient SDS 
polyacrylamide gel and transferred to a polyvinylidene fluoride (PVDF) membrane (BIO-
RAD) with transfer buffer (48 mM Tris/ 39 mM glycine/ 0.037% SDS and 20% absolute 
methanol) using a semidry blotter (Hoefer, 1h at 60 mA). The PVDF membrane was 
blocked by treatment with 5% nonfat milk powder in PBS (blocking buffer) for 30 min and 
then incubated in a solution of the primary antibody diluted with blocking buffer and 0.2% 
Tween 20 for 2 h at room temperature. The blot was washed in PBS containing 0.2% 
Tween 20 three times 10 min, incubated with the secondary antibody for 1 h and finally 
with Streptavidin-HRP for half an hour. The signals were detected with the ECL+ reagent 
according to the instructions of the manufacturer (Amersham). Primary and secondary 
antibodies were used at the following dilutions: 1:5,000 anti-FLAG antibody M2 (Kodak); 
1:10,000 anti-mouse IgG biotin (Amersham); 1:500 Streptavidin-HRP (Amersham). The 
signals were recorded on a luminescent image reader (Fuji). Images were assembled 
and annotated using Adobe Photoshop and Adobe Illustrator on a Power Macintosh 
computer.  
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3.1 GENOMIC STRUCTURE OF DNMT1 GENE 
 
The Dnmt1 protein has a C-terminal (~500 amino acids) domain, sharing motifs (I-X) with 
over 100 prokaryotic 5mC MTases, linked to a N-terminal (~1000 amino acids) regulatory 
domain (see Fig. 1.7). The sequence similarities among mammalian and bacterial DNA 
MTases suggest a common evolutionary origin. A decade ago, it was proposed that the 
mammalian enzyme evolved via fusion of an ancestral prokaryotic restriction MTase gene 
with a second gene based on cDNA sequence and on similarity of the putative peptide to 
bacterial MTases (Bestor, 1990). However, based on comparison of several eukaryotic 
MTases and deletion mapping of the enzymatic activity, we have suggested that MTases 
evolved by fusion of at least three separate genes (Margot et al., 2000). 
At the beginning of this work additional 5’ sequences were identified in the Dnmt1 cDNA 
(Tucker et al., 1996) as well as two different mRNA transcripts (Trasler et al., 1992): one 
present only in testis (pachytene spermatocyte) and a second one characteristic of all 
somatic tissues. 
In order to relate the functional motifs in the Dnmt1 protein with the exon-intron 
boundaries of the Dnmt1 gene and to study the regulation of the new isoforms, the 
elucidation of the genomic structure of the mouse Dnmt1 gene was undertaken. 
Furthermore, the sequence of the 5’ end of the Dnmt1 gene was determined to establish 
the basis for investigating promoter regulation of the different Dnmt1 isoforms.  
Overlapping phage clones, isolated from screening a mouse 129/Sv genomic library and 
subcloned into pSP72 (Promega) or pBluescript KS (pMET in Fig. 3.1, Stratagene), were 
generously provided by Dr. En Li (Charlestown, USA) (Li et al., 1992). The region 
between pSP72RV10 and pSP72S5 was obtained by genomic PCR using DNA prepared 
from frozen 12 day old mouse embryos from strain C57BL6. The genomic DNA was 
extracted as indicated in the Materials and Methods section. One hundred ng of DNA in a 
reaction volume of 100 ml was amplified with a mix of Taq and Pwo DNA polymerases 
(Roche Molecular Biochemicals). The ~ 6 kb PCR product was directly cloned into pCRII 
vector (Invitrogen) and the resulting plasmid designated pCg6. The region upstream of 
pSP72S15 (pCg1 and pCg3) was obtained by a combination of genomic PCR and 
genome walking. The genome walking approach was used to obtain the fragment 
upstream the oocyte specific exon (pCg1) by using genomic DNA, which have been 
digested with five different enzymes and the resulting restriction fragments ligated to an 
adaptor primer. The upstream walk towards the putative promoter from the oocyte exon 
was then carried out following the instructions of the manufacturer (Clontech). PCR 
reactions with reverse primers located in the oocyte exon together with the adaptor 
primers of the genomic DNA fragments were done. The genomic PCR carried out to 
obtain the pCg3 fragment was done with a forward primer located on pCg1 and a reverse 
primer located on pSP72S15.  
In order to determine the sizes of the introns, sequencing (GenBank accession numbers: 
AF 175410-175431, AF 234317-234318) and/or gel electrophoresis of the PCR products 
(Fig. 3.1) were performed. The PCR products containing genomic fragments were 
generated using primers located on both sides of the putative exon boundary. The mouse 
Dnmt1 cDNA was completely resequenced and the revised sequence has been 
submitted to GenBank (accession number AF 162282). The determination of the exon-
intron boundaries (Table 3.1) was carried out by comparing genomic and cDNA 
sequences. Intron localizations at the 3’ end of the Dnmt1 gene were obtained in 
collaboration with the group of Dr. R. J. Roberts (Beverly, USA). 
In this thesis it has been elucidated that the mouse Dnmt1 gene consists of 39 exons and 
spans over 56 kb (Fig. 3.1). The exon sizes vary between 32 (exon 7) and 352 bp (exon 
39) (Table 3.1). The region between the exon 1 and exon 29 contains introns of widely 
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different sizes as well as two very large introns. This region has a low exon density 
(number of exons per unit length). However, the region between exon 30 and 39 harbors 
introns that are smaller and much more uniform in size (Fig. 3.1), this region clearly has a 
higher exon density. The two different exon density patterns correspond to the division 
between catalytic and regulatory domains of the protein proposed before (Bestor, 1990). 
Furthermore, the first exon is located in a CpG island (Fig. 3.8) and is separated from 
exon 2 by a 9.3 kb long intron, which is a typical feature of house keeping genes (Cross 
and Bird, 1995). The region spanning pCg1 until the end of exon 5 (Fig. 3.1) was 
completely sequenced (GenBank accession numbers AF 175410-175412). The TAG stop 
codon was found 39 bp into exon 39 and two polyadenylation signals (AATAAA) were 
found, the first one was mapped 290 bp downstream of the stop codon and the second 
one was identified 274 bp further downstream. 
During the process of this work the structure of the human Dnmt1 gene has also been 
published (Ramchandani et al., 1998). A comparison between mouse and human DNA 
sequences reveals a similar genomic organization. Exon boundaries are conserved in 35 
out of 38 cases. The only exception to a perfectly conserved intron-exon organization is 
the presence of an additional intron in the human gene whose corresponding location 
would be in mouse exon 37. Intron sizes, with the exception of two large introns after 
oocyte and spermatocyte specific exons, range between 77 bp and ~ 3kbp (Table 3.1). 
All 5’ and 3’ splice sites agree with the consensus found for rodents (Senapathy et al., 
1990; Shapiro and Senapathy, 1987) with the exception of the 5’ donor site of intron 10 
where the GT consensus is replaced by GC (Table 3.1). The human Dnmt1 gene has two 
exceptions to the GT/AG rule (Table 3.1), but none correspond to the one in the mouse 
gene. In one case GC replaces GT as splice donor of intron 11, while in the other case 
CT replaces AG as splice acceptor of intron 39 (Ramchandani et al., 1998). 
The location of the conserved motifs of the catalytic domain (Fig. 1.7) (Leonhardt and 
Bestor, 1993) was compared with the intron-exon boundaries (Table 3.1). Three out of 
seven exon boundaries fall within highly conserved motifs and thus indicate that there is 
no correlation between proteins motifs and exon-intron boundaries.  
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Fig. 3.1. Genomic organization of the mouse Dnmt1 gene. At the top of the figure are 
depicted the exons and introns, the restriction map and the localization of the cloned 
genomic DNA fragments within the Dnmt1 locus. B: BamHI; E: EcoRI; S: SalI; X: XbaI. 
The clones denominated pSP72S5 and pSP72S11 share the SalI site in exon 17. 
Plasmid insert sizes are indicated in italics. At the bottom of the figure the intron size 
determinations by agarose gel electrophoresis are shown. MTase specific primers were 
selected within 50 bp on both sides of the putative intron boundary and used for PCR 
amplification. The PCR products were separated on an agarose gel and intron sizes were 
determined from the standard curve of the molecular weight markers. The results are 
summarized in the table 3.1.  
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Table 3.1. The start codon corresponds to the third ATG (ATG3) in exon 1 (Gaudet et al., 
1998). The stop codon (TAG) is located 39 bp into exon 39 and is followed bz a 311 bp 
untranslated region. The lines separating exon 30 and 31 show the separation between 
catalytic and regulatory domains. Intron sizes were determined by sequencing (GenBank 
accession numbers: AF 175410-175431, AF 234317-234318) and/or gel electrophoresis 
(Fig. 3.1). Intron phases are defined as the position of the intron within the codon.  
 
3.2 ALTERNATIVE DNMT1 ISOFORMS DURING 
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GAMETOGENESIS 
 
3.2.1 CLONING OF ALTERNATIVE DNMT1 ISOFORMS FROM TESTIS 
 
In addition to the new 5’ end exon reported by our group (Tucker et al., 1996) a small 
cDNA sequence of 155 bp detected in testis was found through searches in the EMBL 
database (EMBL accession number X 77486). Also, the  presence of a ~ 1 kb larger 
Dnmt1 transcript in testis had been reported (Trasler et al., 1992) part of which could 
correspond to this new EMBL sequence entry. Taken together these results indicated the 
presence of alternative Dnmt1 isoforms in this tissue which interestingly is where 
profound changes in the overall DNA methylation level and pattern occur. Since the 155 
bp cDNA sequence deposited in the database cannot account for the 1kb longer 
transcript found in testis, a screen for the missing cDNA sequence of this new Dnmt1 
isoform was started. Comparison of the EMBL sequence with the Dnmt1 genomic 
sequence (GenBank accession number AF 175410; section 3.1; (Margot et al., 2000)) 
showed that the first 70 bp (depicted in dark blue in Fig.3.2) of the EMBL sequence are 
located  between exons 1 and 2. This 70 bp part of the sequence is testis specific 
(thereafter referred to as testis-specific exon or t-exon) and it is located between 
nucleotides 1937-2005 (GenBank accession number AF 175411; (Margot et al., 2000)), 
the rest of the sequence up to 155 bp corresponds to exon 2 and 48 bp of exon 3 located 
between nucleotides 5242-5278 and 6041-6089 (GenBank accession number AF 
175412; (Margot et al., 2000)) respectively. Taking a closer look at the Dnmt1 gene 
sequence, between the end of exon 1 and the first nucleotide of the 70 bp testis specific 
sequence there is a distance of approximately 800 bp. Therefore, the testis specific 
sequence could either continuously extend at its 5’ end and/or arise from alternative 
splicing. The information obtained from the  genomic localization of the testis specific 
sequence allowed the design of oligos at different positions upstream of this 70 bp 
sequence and the screening of the 5’ end of the Dnmt1 gene by RT-PCR and RACE 
reactions (Fig.3.2).  
Oligos located in the t-exon, exon 1 and exon 4 were selected for the RT-PCR and RACE 
reactions (Fig.3.2A) by using the Lasergene software program (Primer Selection, 
DNASTAR). Commercially available cDNA from mouse testis (Marathon cDNA, Clontech) 
was used for the RACE reactions. The RACE technique is  a variation of the PCR method 
used to amplify cDNAs representing the region between a known point in a mRNA 
transcript and its 3’ or 5’ end (Frohman et al., 1988). A short internal stretch of sequence 
must already be known from the mRNA of interest and from this sequence gene-specific 
primers are chosen that are oriented in the direction of the missing sequence. Extension 
of the partial cDNAs from the unknown end of the message back to the known region is 
achieved using primers that anneal to the preexisting poly A tail (3’ end) or to an 
-PCR, poly A RNA (100 ng) or total RNA (1 mg) were first 
converted into cDNA by reverse transcription using random primers. The subsequent 
PCR reactions were done with 100 ng of cDNA and the primer pairs indicated (Fig. 3.2B). 
The cycling conditions were according to the respective primer pair annealing 
temperatures. Fresh PCR products were then cloned into the pCRII vector (Invitrogen) 
and sequenced.  
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The size, sequence and location of the oligos used are shown in the table below: 
 
Oligo 
Nr. 
Location  Used 
for: 
Sequence 
243 (F) exon1 RT-PCR 5’ AAG ATG CCA GCG CGA ACA 3’ 
238 (R) exon4 RT-PCR 5’ TTG GCT TTT TGA GTG AGA 3’ 
242 (F) exon1 RT-PCR 5’ GGC TCG CTC CCG GAC CAT 3’ 
241 (R) t-exon RT-PCR 5’ TGC CAT CCC TCA CTC CTC 3’ 
347 (R) exon4 RACE 5’ GGC TTT TTG AGT GAG AGT GTG TGT TCC G 3’ 
348 (R) t-exon RACE 5’ TGC CAT CCC TCA CTC CTC GAA ATA AAC 3’ 
 
Two new isoforms were obtained (Fig. 3.2C): one was obtained by RT-PCR showing a 
new splicing variant and the second one was obtained by RACE analysis containing an 
extension of 316 bp at the 5’ end of the t-exon. Further RACE analysis showed that the t-
exon in this isoform is ~ 800 bp. The new splicing  variant  starts with exon 1 and  
continues with  88 bp  of the t-exon (Fig. 3.2C). The exon-intron boundaries for this 
splicing variant match the GT/AG consensus (see also section 3.1). Due to the low 
abundance of this new isoform and the difficulty to obtain it, this isoform was not further 
investigated. The next sections therefore refer to the isoform obtained by RACE analysis. 
While this work was in progress a testis-specific Dnmt1 isoform was reported which 
corresponds to the one obtained by RACE, whose 5‘ boundary is approximately 80 
nucleotides downstream of the 3‘ end of exon 1 of the ubiquitous mRNA (5.4 kb, Fig. 3.3). 
Furthermore in the ovaries a first exon specific to oocyte Mertineit, 1998 # 24 substitutes 
exon 1 and is located in the Dnmt1 gene  7 kb upstream of exon 1 (Fig. 3.10). 
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Fig. 3.2. Alternative dnmt1 isoforms in testis. (A) Short Dnmt1 genomic scheme with 
the location of the oligos used. (B) Agarose gels showing the products from the RT-PCR 
(this reaction was carried out in duplicate) and the RACE reactions, the oligos used are 
indicated on top of each of the gels. The PCR control without cDNA is indicated with a 
minus sign (-) .  (C) Two new alternative Dnmt1 isoform are depicted. By RT-PCR, with 
random oligos and subsequent nested PCR with the oligos indicated, a new alternative 
splicing form was found starting with exon 1 and continuing with 88 nucleotides of the 
testis specific exon (dark blue). By RACE analysis an extension (light blue) of the 5‘ end 
of the t-exon was obtained using the oligos depicted in the panel B. A first RACE reaction 
was done with oligo 347 in combination with the adaptor primer 1 (AP1). An aliquot from 
this first reaction was then used in a second nested RACE reaction with oligo 348 in 
combination with adaptor primer 2 (AP2). 
 
3.2.2 EXPRESSION OF THE DNMT1 ISOFORMS BY NORTHERN  
BLOT ANALYSIS 
 
To find out the transcript size, tissue distribution and expression level of the Dnmt1 
isoforms Northern blot analysis was performed. Blots containing poly A RNA from mouse 
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testis (Clontech) were used. Three different cDNA probes were used for the Northern 
hybridizations are represented by color coding in Fig.3.3 and these are: a 377 bp 
(nucleotides 674 to 1050) and a 950 bp (nucleotides 2946 to 3895) corresponding to the 
N-terminal and C-terminal region of Dnmt1 respectively (GenBank accession number AF 
162282; (Margot et al., 2000)) depicted in green in Fig.3.3. After hybridization with these 
probes, signals were detected and the blots were stripped by boiling with SDS solution 
(0.5% SDS) twice for 15 min, before being rehybridized with the next probe. Also a 396 
bp probe (nucleotides 1621-2016, GenBank accession number AF 175411; (Margot et 
al., 2000)) was used, this fragment corresponds to the testis specific exon (Fig. 3.2C and 
also Fig. 3.3 depicted in blue). Finally, a mouse b-actin probe was hybridized to the blots 
to control for RNA loading. Labelling of the probes, hybridization, washes and exposure 
were done as described before (see Materials and Methods). The blots were exposed to 
a phosphorimager screen, scanned on a phosphorimager with the Image Quant software 
(Molecular Dynamics) and the results are shown in Fig. 3.3. 
The use of two probes, depicted in green in Fig. 3.3, detected a Dnmt1 transcript of 5.4 
kb that is present in all tissues assayed. Its size was determined by comparing with the 
standard curve generated from the molecular weight markers. When differences in the 
amount of RNA loaded (as determined by probing the blot with b-actin) were taken into 
account, the 5.4 kb Dnmt1 transcript was most abundant in heart and brain. Examination 
of the phosphorimages after longer exposure showed the presence of a slower migrating 
mRNA transcript of 6.2 kb that was present in testis and in skeletal muscle.  
To investigate the structure of these longer transcripts blots were stripped and reprobed 
with a new probe containing testis specific sequences. If the slower mRNA transcript 
band (detected with the green depicted probes (Fig. 3.3)) contains the same sequences 
in testis and skeletal muscle, then it was expected to see this transcript in both organs 
when using a testis specific probe (depicted in blue in Fig. 3.3). However, the 6.2 kb 
transcript was detected by the testis specific probe only in testis and not in skeletal 
muscle. It might be that this slower migrating band in testis differs from the one present in 
skeletal muscle, or that the levels of the skeletal muscle transcript are so low that its 
presence is difficult to detect by Northern blot analysis. Higher amounts of RNA from 
skeletal muscle were tried but did not give interpretable results in part due to the lack of 
separation of high amounts of RNA on formaldehyde gels. 
 
 
Fig. 3.3. Expression of Dnmt1 mRNA in different mouse tissues.  The figure shows 
Northern blots containing polyA RNA from the mouse tissues indicated. The blots were 
hybridized with three probes as indicated by the color coding. The black vertical bar 
indicates the separation between the N- and C-terminal domains. In the case of brain and 
heart tissue where Dnmt1 mRNA levels were high, a shorter exposure is shown 
underneath the corresponding blot. All blots were reprobed with a b-actin probe as a 
loading control.  
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3.2.3 LOCALIZATION OF THE DNMT1 ISOFORMS BY IN SITU 
HYBRIDIZATION ANALYSIS 
 
The RACE and RT-PCR as well as the Northern blot analysis have shown that at least 
two major isoforms of Dnmt1 are present, one that is ubiquitously expressed and the 
other that is detected in testis and in skeletal muscle. To analyze the localization of these 
isoforms at the cellular level, the in situ hybridization technique was used. The following is 
a brief introduction to the morphology and development of the testis to allow the 
identification of the mouse testis cells where the Dnmt1 isoforms were localized.  
The testis has two major components: the intertubular or interstitial compartment 
(interstitium) and the seminiferous tubule compartment. The interstitial compartment 
contains the blood and the lymphatic vessels. The seminiferous tubules are convoluted 
loops that have their two ends connected into the beginning of the rete testis. Although 
numerous convolutions are present in each loop, the tubules straighten between 
convolutions and travel largely in the long axis of the testis (Fig. 3.5C). As a result of this 
pattern of organization, a transverse histological section through the long axis of the testis 
can be used to visualize cross-sectioned tubules (Fig. 3.5C).  
The adult mammalian testis contains male germ cells in all stages of development as well 
as several somatic cell types, including Sertoli, Leydig, and interstitial cells. The process 
of spermatogenesis can be divided into three main phases; a mitotic phase in which stem 
cells, called spermatogonia, replicate DNA and divide; a meiotic phase in which 
spermatocytes undergo genetic recombination and meiosis; and a differentiation phase, 
spermiogenesis, in which haploid cells, spermatids, acquire the specialized flagellum, 
Golgi, nucleus and mitochondria of the mature spermatozoon. During the differentiation 
or spermiogenesis, the spermatids transform themselves into cells structurally equipped 
to reach and fertilize the egg (Fig. 3.4 and Fig. 3.5 C). The cells in the first meiotic 
prophase, primary spermatocytes, can be further subdivided according to the stages of 
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meiosis, preleptotene, leptotene, zygotene, pachytene and diplotene. The haploid phase 
can also be subdivided into a series of steps based on the morphology of the developing 
spermatids. The number and morphological characteristics of the steps differ slightly 
among mammals, in the case of mice 16 can be distinguished. In mice, cells in steps 1-8, 
round spermatids, are characterized by round, decondensed nuclei; cells in steps 9-early 
12 are known as elongating spermatids, because the nuclear shape changes from round 
to elongated; and cells in the remaining steps are referred to in general as elongated 
spermatids (Fig. 3.4). 
 
 
Fig.3.4. Map of the cycle of the seminiferous epithelium of the mouse (Russell et 
al., 1990). The developmental progression of a cell is followed horizontally until the right 
hand border of the cycle map is reached. The cell progression continues at the left of the 
cycle map one row up. The vertical columns, designated by Roman numbers, depict cell 
associations (stages), meaning the different cell types that can be found in a testis cross 
section. In, intermediate spermatogonia; B, type B cells; Pl, preleptotene; L, leptotene; Z, 
zygotene; P, pachytene; D, diplotene. 
 
The Northern blot analysis indicated the presence of two (6.2 and 5.4 kb) Dnmt1 
transcripts in two tissues. The next step was to find out where these transcripts were 
localized at the cellular level in the organs that showed the new slower migrating 
transcript (6.2 kb) by Northern blot analysis. Dnmt1 cDNA fragments (containing the 
areas depicted in Fig. 3.5A and B as blue and green) were cloned in the pCRII vector 
(Invitrogen). This vector contains T3 and T7 promoters in opposite sides of the multiple 
cloning site, allowing RNA to be transcribed in vitro from either strand of the insert. The 
cDNA fragments were cloned downstream from the T7 (depicted in blue) and from the T3 
(depicted in green) RNA polymerase dependent promoter (Fig. 3.5A and B). The single 
stranded antisense (sense for the control) RNA probes were synthesized with the 
appropriate RNA polymerase and radioactive nucleotides by using an in vitro transcription 
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system (Promega). The radioactively labeled RNA transcripts were then hybridized with 
cryo sections of testis and skeletal muscle. The appropriate Dnmt1 RNA probe was 
diluted in hybridization buffer and hybridized with the tissue sections overnight. The 
prehybridization times and the temperature for hybridization were optimized. The optimal 
conditions were found to be 37oC for prehybridization for a minimal of 4 hours and 42oC 
overnight for hybridization. Under these conditions the maximum sensitivity and the 
lowest background was obtained. Concurrently with the slides containing the antisense 
probe, adjacent tissue sections were also included containing a sense RNA probe as 
control for genomic DNA hybridization and unspecific binding. Signals were detected as 
described in Materials and Methods. 
 
Fig. 3.5. Localization of Dnmt1 mRNA in different adult mouse tissues and embryo. 
(A) and (B) show cryo sections of mouse testis, skeletal muscle and 13 day-old embryo. 
The hybridizations were done using probes as indicated by the color coding. Sagittal 
sections were used for skeletal muscle and embryo and for testis cross sections. Very 
weak signals (black dots) are seen in skeletal muscle (A) using the probe (depicted in 
blue) which also highlights the 6.2 kb band corresponding to the testis mRNA in the 
Northern blots (Fig. 3.3). When using the same probe in testis sections clear signals are 
localized on the cells closest to the lumen (spermatids). However, when using a probe 
that spans most of the cDNA (depicted in green), the signals are seen in most of the 
cells. The probe, depicted in blue, was used for embryo sections (B). Areas localized in 
the ear such as the lateral wall of right posterior semicircular canal (1) and right tubo 
tympanic recess (2) and also areas on the hip joint such as acetabular fossa (3) showed 
the presence of this transcript in embryo sections. The exposure times were 2 weeks for 
testis and embryo and 4 weeks for skeletal muscle. Negative controls (sense probe) were 
hybridized to adjacent sections. (C) Cross section of a seminiferous tubule. The 
schematic outline was taken from Clermont et al., (Clermont and Huckins, 1961) and the 
diagram showing the different types of cells on a cross section from testis was taken from 
Setchell et al., (Setchell et al., 1994). SG; spermatogonia, SC; primary spermatocyte, SD; 
spermatid, S; sertoli cell. (D)The ear and the hip anatomy are shown and the schematic 
outlines were taken from  http://www.bcm.tcm.edu/oto/studs/anat/tbone.html#ear and 
http://www.acay.com. au/~dissi/sbc /hipdys.htm, respectively. Ear anatomy, (1) 
Semicircular canals and (2) Tympanic membrane are indicated in the figure. Hip 
anatomy, (1): Centre of the femoral head; (2): Cranial acetabular edge; (3): Acetabular 
fossa; (4): Cranial effective acetabular edge; (5): Dorsal acetabular edge; (6): Caudal 
acetabular edge; (7): Femoral head/neck reconturing; (8): Femoral ahead reconturing.   
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When the probe which detects the ubiquitously expressed isoform (depicted in green in 
Fig. 3.5A) was hybridized to cross sections from mouse testis, all the cells that 
surrounded the lumen were labeled as shown by the black dots. When a probe that 
recognizes a sequence localized in the testis isoform was used (depicted in blue in Fig. 
3.5A) the signals were more specific and localized to the spermatids which are the cells 
closer to the lumen. Adjacent cross sections that were labeled with a sense probe were 
used as a negative control and the absence of black dots in the whole section indicates 
the specificity of both antisense probes. The exposure times for the testis sections were 
~10 days. A larger form of Dnmt1 mRNA (which corresponds to the form depicted in blue 
in Fig. 3.5A) was shown to be present only in pachytene spermatocytes (Trasler et al., 
1992) (see also Fig. 3.4). In these experiments isolated populations of male germ cells 
were used to prepare RNA for Northern blots . In these type of experiments it would be 
difficult to have pure populations of each cell type and thus contaminations by other cell 
types are difficult to avoid. 
The same probe that hybridizes  only  to spermatids in testis sections (depicted in blue) 
was also used for skeletal muscle (sk. muscle) (Fig. 3.5A). Sagittal skeletal muscle 
sections were hybridized with the mentioned probe and after 4 weeks exposure very 
weak signals were detected, which suggests a low abundance of this transcript in this 
tissue. The sense control showed no signal. 
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To investigate whether this isoform is expressed during development and if so in which 
cell types, sagittal sections of whole mouse embryos (day 13) were hybridized to the 
probe corresponding to the t-exon (depicted in blue in Fig. 3.5A and B). The positive 
signals obtained were localized in cartilages of the ear and hip. Two areas of the ear 
where this isoform was localized were the lateral wall of right posterior semicircular canal 
and the right tubo tympanic recess (Fig. 3.5B; 1 and 2 respectively). Briefly, the ear can 
be divided into two areas the middle and the inner ear. It is in the inner ear where the 
cochlea which is the hearing part and the semicircular canals (Fig. 3.5D; ear anatomy) 
are located. The semicircular canals are not part of the hearing function,  they are part of 
the balance system. For example, when a movement is done to turn the head, the fluid in 
the canal moves the tiny hairs of the nerve endings and bend them. Nerve impulses 
travel to the brain, giving information about the direction in which the head is moving. The 
other area in the embryo expressing the new isoform is the acetabular fossa which forms 
part of the hip (Fig. 3.5D, 3; hip anatomy). The new transcript has been detected in 
cartilages located in the ear (Fig. 3.5B, 1 and 2) and the area of the hip where this 
alternative transcript was present has also been reported to contain a cartilage covered 
part (Stener and Peterson, 1981). The skeletal muscle showed no detectable signals, in 
the 13 day-old embryo, when using the probe depicted in blue. 
In summary, two Dnmt1 transcripts are present: one that is ubiquitously expressed  (5.4 
kb) and a larger transcript (6.2 kb), which is present only in adult mouse testis and 
skeletal muscle. The slower migrating transcript has been further analyzed at the cellular 
level in testis sections and localized to the spermatids.  
 
3.2.4 LOCALIZATION OF THE DNMT1 PROTEIN IN MALE AND 
FEMALE GERM CELLS 
 
Overall DNA methylation changes dramatically during gametogenesis (see section 1.2.1) 
and therefore, in addition to the mRNA analysis, the level and localization of the Dnmt1 
protein was studied in sections from ovaries and testis by immunohistochemistry.  
In the female mouse the germ cells pass throught several oogonial divisions and reach 
the oocyte stage during embryonal development. About 3 days after birth the oocytes 
reach a static state known as the dictyate stage, which is maintained until a few hours 
before ovulation. A few days after birth some antra appear and the ovum reaches its 
maximum size at the time that antrum formation begins. Once oogenesis has begun, it 
continues in regular 4 1/2 to 5 day cycles throughout the reproductive life to about 12 or 
14 months of age. A brief summary of the stages of oogenesis is depicted in the Fig. 
3.6A. Briefly, after ovulation, the dominant follicle, reorganizes to become the corpus 
luteum. Thus, following rupture of the follicle, capillaries and fibroblasts from the 
surrounding stroma proliferate and penetrate the basal lamina and a rapid vascularization 
of the corpus luteus takes place. The granulosa cells present undergo morphological 
changes and this process is referred to as luteinization. These latter cells, the 
surrounding interstitial cells and the invading vasculature, give rise to a corpus luteum. It 
is this endocrine gland which is the major source of sex steroid hormones secreted by the 
ovary during the postovulatory phase of the cycle. 
Ovaries and testis which were previously embedded in paraffin were sectioned and 
stained with the antibody pATH5, which recognizes multiple epitopes within the region 
between aminoacids 255-753 (Leonhardt et al., 1992; Li et al., 1992), which are present 
in both isoforms. The Dnmt1 protein is very abundant in oocytes as seen in Fig. 3.6B 
where mainly the cytoplasm is stained. In Fig. 3.6B a mature follicle is shown where the 
antrum (Fig. 3.6A and B) is already formed and the oocyte harbored in this cavity is 
intensively stained. The oocytes used were from adult female mice which explains the 
strong cytoplasmic staining. Mertineit et al. (Mertineit et al., 1998) recently showed 
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dramatic changes in the amount and localization of Dnmt1 during oogenesis. Growing 
oocytes showed intense nuclei and substantial cytoplasmic staining. At later stages of 
oocyte growth, Dnmt1 is no longer detectable in nuclei but accumulates to high levels in 
the cytoplasm. The Dnmt1 protein was also detected in the lutein cells (Fig. 3.6B).  
 
 
Fig. 3.6. Localization of Dnmt1 during oogenesis.  (A) Scheme of the development of 
an ovarian follicle is depicted (figure modified from R. Rugh). (B) Localization of the 
Dnmt1 protein by immunofluorescence staining with the rabbit polyclonal pATH5 
antibody, detected with the Rhodamine conjugated anti-rabbit IgG antibody. The DNA 
counterstaining was performed with Hoechst 33258 to locate cell nuclei. The Dnmt1 
protein is localized on the cytoplasm of the oocyte as indicated by the intense staining 
with the pATH5 antibody. – Ab control: represents the control without the first antibody.  
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Fig. 3.7. Localization of Dnmt1 in seminiferous tubules.  The figure shows the 
localization of the Dnmt1 protein by inmunofluorescence staining with the rabbit 
polyclonal pATH5 antibody, detected with the Rhodamine conjugated anti rabbit IgG 
antibody. The DNA counterstaining was performed with Hoechst 33258 to locate the cell 
nuclei. The Dnmt1 protein  is localized in spermatogonial cells which are the cells with a 
basal localization. The Dnmt1 is also seen in spermatids which are the cells closer to the 
lumen. –Ab control: indicates the control without the first antibody. 
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The Dnmt1 staining in testis was localized to the spermatogonia, which are the mitotically 
active stem cells that lie at the basal side of the seminiferous epithelium, and in some 
primary spermatocytes, which are the next type of cells found in a testis cross section 
and are less basal than the spermatogonia cells. The spermatids also showed positive 
signals in some of the testis sections. These are the most specialized testis cells and 
correspond to a stage just previous to the formation of spermatozoon, in which the 
spermatids undergo morphological modification in a process called spermiogenesis (Fig. 
3.4). However, the background level in the spermatids is high which makes it difficult to 
evaluate the signal observed in these cells. It is interesting that the new alternative Dnmt1 
transcript has also been localized to these cells by in situ hybridization (Fig. 3.5A), 
suggesting that this Dnmt1 protein staining (Fig. 3.7) could correspond to this isoform. 
That would contradict a recent report (Mertineit et al., 1998) proposing that this transcript 
is not translated.   
 
3.3 EXPRESSION OF DNMT1 ISOFORMS DURING 
MYOGENESIS 
 
3.3.1 CLONING OF THE ALTERNATIVE DNMT1 ISOFORM FROM 
SKELETAL MUSCLE 
 
In mammals, levels of 5mC increase not only during gametogenesis but also after 
implantation when tissue specific patterns are established (Monk, 1990). During 
differentiation, when tissue specific genes begin to be expressed, the promoter regions of 
many of these genes are demethylated while the ones from inactive genes are 
methylated. One of the best characterized systems to study establishment of tissue 
specific gene expression is the skeletal muscle system, but conflicting data have been 
published concerning the role of DNA methylation during skeletal myogenesis. Thus on 
one hand, artificially induced demethylation seems to stimulate myogenic differentiation 
(Jones and Taylor, 1980), which is in accordance with the observation that the somatic 
Dnmt1 isoform is downregulated during myogenesis (Liu et al., 1996). On the other hand 
ectopic overexpression of a truncated Dnmt1 protein in undifferentiated myoblasts leads 
to changes in gene expression and induction of myogenic differentiation (Takagi et al., 
1995). The Northern blot analyses presented in Fig. 3.3 indicated the presence of two 
transcripts of 5.4 and 6.2 kb not only in testis but also in skeletal muscle. The shorter 
transcript corresponds to the ubiquitously expressed Dnmt1 described before (Tucker et 
al., 1996; Yoder et al., 1996) but the longer transcript in muscle had not been previously 
reported and could correspond to an alternative isoform with potentially new properties. 
To isolate the cDNA corresponding to this alternative transcript, a combination of RACE 
and RT-PCR was used.  
The Dnmt1 cDNA has been shown to have 39 exons and to span over 56 kb (see section 
3.1. Genomic structure). RT-PCR products from skeletal muscle RNA were compared 
with the previously described somatic isoform of Dnmt1 (Tucker et al., 1996) from exon 5 
to 37 to search for potential alternatively spliced exons (Fig. 3.8B). The oligos used in the 
PCR reactions as well as their exon localization and sequence are shown on the table 
below where the primer pairs are separated by horizontal lines.  
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Oligo Nr. Location Sequence 
58 (F) exon20 5’ GAG CCA GGT AGA GAG TTA 3’ 
61 (R) exon23 5’ CAC CGC CAA GTT AGG ACA 3’ 
52 (F) exon5 5’ ACC ATC ACG GCT CAC TTC 3’ 
55 (R) exon12 5’ TCC TTG GGT CTC CGT TTG 3’ 
70 (F) exon35 5’ CCC TTC CGA ACC ATC ACC 3’ 
72 (R) exon37 5‘ GCA GGC ACC AGG GGA TGA 3’ 
60 (F) exon23 5’ GGC GGT GAA GGA GGC AGA 3’ 
63 (R) exon25 5’ AGG GGC TTT GTA GAT GAC 3’ 
54 (F) exon12 5’ AAC GGA GAC CCA AGG AAG 3’ 
57 (R) exon17 5’ ACA CCC AGA AAA GTA GAG 3’ 
62 (F) exon25 5’ AAG GTC AAG GTC ATC TAC 3’ 
65 (R) exon28 5’ TTC TCC CCT TGA TGT AGT 3’ 
56 (F) exon17 5’ GGG CAC CTG TGT CCT GTC 3’ 
59 (R) exon20 5’ TGG GGG TCT CAT CAT CGT 3’ 
64 (F) exon28 5’ TCG GTC GGA TAA AAG AGA 3’ 
72 (R) exon37 5‘ GCA GGC ACC AGG GGA TGA 3’ 
 
The oligos were 18 mers with low melting temperatures, thus annealing temperatures 
used in the PCR reactions were in the range of 40-45oC. 
The PCR product from the plasmid containing the ubiquitously expressed cDNA was 
always run on the left hand side from the PCR product obtained with cDNA from skeletal 
muscle as seen in part B from Fig. 3.8. Negative controls were also included in the 
reactions: one negative control for the PCR reaction which has all the PCR reagents 
except the cDNA and a RT negative control which includes all the reagents necessary to 
perform the RT reaction but not the enzyme (reverse transcriptase). The PCR products 
were in the range of 417-475 bp except for one that was 1500 bp long, due to the 
difficulties to find good primer pairs in the region. The negative controls showed no bands 
indicating the specificity of the PCR and RT reactions. No differences were found from 
exon 5 to exon 37 when screening for the presence of alternative exons by comparing 
RT-PCR products from skeletal muscle cDNA with a plasmid containing the ubiquitously 
expressed Dnmt1 cDNA (Tucker et al., 1996). 
The next step was to test whether new 3’ or 5’ exons are present in this alternative 
transcript by performing RACE reactions using gene-specific primers located in exon 37 
and 4, respectively. The products obtained in both reactions were cloned and sequenced. 
From the 3’ RACE reaction the sequences obtained (Fig. 3.8A) contained exons 37 to 39 
from the previously described somatic isoform of Dnmt1 and utilization of the first 
polyadenylation site (red box in Fig. 3.8A, see section 3.1. Genomic structure) (Margot et 
al., 2000), and therefore can not account for the longer mRNA found by Northern blot 
analysis in skeletal muscle (6.2 kb in Fig. 3.3). However, from the 5’ RACE reactions two 
different size products were obtained and the respective sequences contained either 
exon 1 to 4 of the previously described ubiquitously expressed isoform (Tucker et al., 
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1996) or the t-exon followed by exons 2 to 4 (Fig. 3.8C). Since no longer RACE products 
were obtained, RT-PCR reactions using primers located at different positions in the 
genomic region upstream of the 5’ end of the RACE product corresponding to the testis 
specific isoform were used to map the beginning of this exon in the skeletal muscle 
isoform. The oligos used in these RACE and PCR reactions as well as their exon 
localization and sequence are shown on the table below where primer pairs are 
separated by horizontal lines. Primers 371 and 347 were used in RACE reactions.  
 
Oligo Nr. Location  Sequence 
371 (F) exon1 5’ AAT TCA GCA CCC TCA TCC CCT GGT GCC T 3’ 
347 (R) exon4 5’ GGC TTT TTG AGT GAG AGT GTG TGT TCC G  
297 (F) t-/sk.m 
ex. 
5’ GCC CCC GCC CTA TTA TTT TA 3’ 
401 (R) exon5 5’ TGA TGG TGG TCT GCC TGG T 3’ 
297 (F) t-/sk.m 
ex. 
5’ GCC CCC GCC CTA TTA TTT TA 3’ 
420 (R) exon4 5’ TTC CCC TCT TCC GAC TCT TC 3’ 
297 (F) t-/sk.m 
ex. 
5’ GCC CCC GCC CTA TTA TTT TA 3’ 
403 (R) t-/sk.m 
ex. 
5’ CTG GTG TGA CGT CGA AGA CT 3’ 
320 (F) t-/sk.m 
ex. 
5’ ATG CGC GGG GCA GCG TTT 3’ 
316 (R) t-/sk.m 
ex. 
5’ TAA AAT AAT AGG GCG GGG GC 3’ 
 
The primers used for these reactions were 18-20 mers and the annealing temperature 
used in the PCR reactions was 55oC. Some of the primer combinations and reaction 
products are shown in Fig. 3.8C . 
The sequence of the longest 5’ extension product amplified from skeletal muscle RNA is 
shown at the bottom of Fig. 3.8C (GenBank accession number AF 175432). This 
sequence turns out to be identical to the one identified in testis (section 3.2.1). 
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Fig. 3.8. Cloning of the skeletal muscle Dnmt1 isoform. (A) 3’ RACE was used to 
screen for differences at the 3’ end which could account for the novel Dnmt1 transcript in 
skeletal muscle. A forward oligo in exon 37 (371) in combination with the adaptor primer 
(AP) were used. The PCR reaction was carried out in duplicate and the agarose shows 
the PCR products obtained whose size corresponds to approximately 800 bp. The PCR 
products were then cloned into the pCRII vector (sequence in capital letters) and 
sequenced. sk.m, corresponds to PCR product from skeletal muscle cDNA; -, represents 
the minus cDNA control PCR. The sequence obtained shows no new exons (from exon 
37 to 39) and utilization of the first polyadenylation signal (indicated by a red box)(section 
3.1 and (Margot et al., 2000)).  (B) Screening for the presence of alternative exons by 
comparing RT-PCR products from skeletal muscle cDNA with a plasmid containing the 
ubiquitously expressed Dnmt1 cDNA. Skeletal muscle RNA was reverse transcribed 
using random primers. Different PCR reactions were done using oligo pairs as indicated, 
spanning the known Dnmt1 cDNA from exon 5 (ex. 5) to exon 37 (ex. 37). –RT, 
corresponds to the negative control without reverse transcriptase; -, corresponds to the 
negative control for the PCR reaction without cDNA template; C, PCR product from the 
plasmid; sk. m, PCR product from skeletal muscle cDNA. (C) To screen for new 5’ end 
and/or alternative exons, a combination of oligos were used in 5’ RACE and RT-PCR 
reactions using skeletal muscle mRNA. The corresponding location of the primers used 
and the 5’ genomic structure (Margot et al., 2000) (see also Fig. 3.10) of the ubiquitous 
Dnmt1 (exon 1 to 9) as well as the testis specific isoform (indicated in blue) are depicted 
in the diagram. Reverse transcriptase reactions were done both with random and with 
and oligo (403) located in exon 9, and the RACE reaction with an oligo positioned in exon 
4. –RT, as in (B); -, as in (B); +, positive PCR control. All the PCR products were cloned 
into pCRII and sequenced. From the RACE reactions two isoforms were obtained 
multiple times, which contain either exon 1 or the isoform isolated from testis (section 
3.2.1). RT-PCR analysis using primers at different positions of the testis specific exon 
further confirmed the presence of this isoform in skeletal muscle mRNA. The sequence of 
the longest PCR product (GenBank accession number AF 175432) is shown underneath 
and the different exons are color coded as in the genomic structure.   
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3.3.2 THE ALTERNATIVE MUSCLE ISOFORM IS EXPRESSED 
SPECIFICALLY IN DIFFERENTIATED MYOTUBES 
 
The identification of this alternative Dnmt1 isoform in skeletal muscle raises the question 
of when it is expressed during myogenic differentiation. To answer this question a well 
characterized in vitro differentiation system that is based on the ability of C2C12 mouse 
myoblasts (MB) to spontaneously differentiate into myotubes (MT) upon mitogen 
withdrawal (Fig. 3.9A) was used in this study. RNA from proliferating myoblasts as well as 
from differentiated myotubes was isolated and the expression of the two Dnmt1 isoforms 
was analyzed by RT-PCR using upstream primers located either in exon 1 or in the t-
/skeletal muscle specific exon (Fig. 3.9B). The ubiquitously expressed isoform containing 
exon 1 was present in both myoblasts and myotubes albeit at a lower level in 
differentiated cells (Fig. 3.9C). This is in agreement with a previous report showing a 
similar transcription rate but a shorter half-life of the mRNA for Dnmt1 in differentiated 
mouse myotubes using a different myoblast cell line (Liu et al., 1996). The new isoform, 
however, was not detectable in undifferentiated myoblasts and was only expressed in 
differentiated myotubes (Fig. 3.9C). Equal amounts of input cDNA were present in both 
cases as shown by the similar amounts of GAPDH specific PCR fragment obtained using 
the same cDNA samples (Fig. 3.9 C). As a differentiation control primers specific for the 
mouse myogenin cDNA , a skeletal muscle specific transcription factor, which is 
expressed only after the onset of terminal differentiation (Andres and Walsh, 1996), were 
used. As expected, myogenin could only be amplified from myotube RNA (Fig. 3.9C). 
These results show that this alternative Dnmt1 isoform is specifically expressed in 
myotubes during myogenesis.  
 
Fig.3.9.  (A) The images and diagram above illustrate the myogenic differentiation 
system. Upon serum deprivation myoblasts (MB) fuse to form multinucleated myotubes 
(MT) which express several muscle-specific proteins such as the basic helix-loop-helix 
transcription factor myogenin. (B) Location of the oligos used for RT-PCR. (C) RT-PCR 
products (with and without reverse transcriptase, + and -) were analyzed in agarose gels. 
A 343 bp fragment was obtained in MT but not in MB using oligos located in the 
testis/skeletal muscle exon (depicted in blue) and in exon 4. For the ubiquitously 
expressed isoform, oligos located in exon 1 and exon 4 were used in the RT-PCR 
reaction, and the expected fragment of 264 bp was obtained in MB and at lower level in 
MT. RT-PCR with GAPDH specific oligos was used as a loading control giving rise to the 
463 bp product seen at equal amounts in MB and MT. As a control for myogenic 
differentiation oligos that amplify a 450 bp fragment of the myogenin transcription factor 
were used and, as expected, a product is obtained in MT and not in MB. 
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3.4 GENOMIC ORGANIZATION OF THE DNMT1 
ISOFORMS 
 
The most prominent Dnmt1 isoforms seem to be generated by alternative transcriptional 
start sites. Therefore the 5’ end of the Dnmt1 gene was sequenced (GenBank acession 
number AF 175410-175413; about 26 kbp from the oocyte-specific exon to exon 9). In 
Fig. 3.10 the structure of the 5’ end of the three Dnmt1 isoforms identified so far is shown 
together with their genomic localization and their tissue distribution. Since these three 
alternative exons are not expressed in single tissues and to avoid confusion by exons 
identified in the future, they were renamed according to the chronological order of their 
identification: 1a, exon 1 (Tucker et al., 1996); 1b, spermatocytes (Mertineit et al., 1998), 
spermatids and skeletal muscle exon (this work); 1c, oocyte exon (Mertineit et al., 1998). 
To identify CpG islands in the 5’ end of the Dnmt1 gene the CpG versus GpC sites (Fig. 
3.10) are shown. The only CpG island identified between exon 1c and exon 3 is located 
around exon 1a, the start of the ubiquitously expressed isoform, and stretches till the start 
of tissue-specific exon 1b. In comparison, no CpG island could be identified around exon 
3, which had previously been described as transcriptional start site of the ubiquitously 
expressed isoform (Rouleau et al., 1992). Since transcriptional start sites of 
housekeeping genes are typically associated with CpG islands, these results further 
support a transcriptional start of the ubiquitously expressed form with exon 1a. 
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Fig. 3.10. The mouse Dnmt1 gene contains at least three alternative exons at the 5’ 
end. The diagram depicts the genomic structure of the 5’ end of murine Dnmt1. Three 
alternative 5’ exons have been identified: one is specific to the oocyte, one to the testis 
and skeletal muscle and one to somatic cells. The exons of Dnmt1 are represented to 
scale with respect to their size and relative position in the gene (GenBank accession 
number AF 175410-175412). The exons present in each isoform are indicated and are 
renamed following the chronological order of identification: 1a, exon 1 (Tucker et al., 
1996); 1b, spermatocytes (Mertineit et al., 1998), spermatids and skeletal muscle exon 
(this work); 1c, oocyte exon (Mertineit et al., 1998). CpG and GpC incidence diagrams 
are plotted below to scale. The presence of a CpG island around exon 1a is a typical 
feature of housekeeping genes and fits well with the ubiquitous expression of this 
isoform.  
 
3.5 TRANSLATION EFFICIENCY OF THE TESTIS/ SKELETAL 
MUSCLE ISOFORM 
 
Sequence analysis of the alternative Dnmt1 transcript expressed in skeletal muscle and 
in testis revealed several short ORFs (Fig. 3.11). The first ATG is in-frame these short 
upstream ORFs has been previously proposed to prevent translation of this isoform in 
spermatocytes (Mertineit et al., 1998). The expression of an untranslatable mRNA, 
however, could hardly play an active role in the regulation of DNA methylation. Also, the 
5’end of the Dnmt1 transcript found in oocytes contains several short upstream ORFs 
(Mertineit et al., 1998) and yet is highly expressed in vivo (Fig. 3.6). Even the ubiquitously 
expressed form includes in the first exon (1a) three ATGs and only the third one is utilized 
in vivo (Gaudet et al., 1998).  
To answer the question whether the skeletal muscle and testis Dnmt1 transcript could be 
translated in vivo, a set of mammalian expression constructs containing the entire exon 
1b as well as 5’ truncated forms that contain only some of the short upstream ORFs were 
generated. The different Dnmt1 pCR3.1 expression plasmids are designated 1a-9, 1b-9, 
1b’-9, 1b’’-9 and 3-9 (numbers correspond to exons present; see Fig. 3.10 for 
nomenclature of exons). To generate these constructs paired fragments of double 
stranded DNA, containing a common region that can be annealed after denaturation were 
used (see diagram on Fig.3.11A). Briefly, for each construct two paired PCR products of 
double stranded DNA were mixed with all the reagents necessary for a PCR reaction 
except the oligos. The oligo sequence and exon localization are indicated on the table 
below (oligo pairs are separated by horizontal lines). The oligo pairs were as follows: 
(584-582, 583-578) for 1a-9, (320-316, 579-578) for 1b-9, (579-581, 577-578) for 1b’-9. 
The mixture was then allowed to denature, anneal and extend for one cycle on a PCR 
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machine (Biometra). After this initial cycle, oligos flanking the newly formed double 
stranded DNA were added to the reaction and the PCR was carried out for another 30 
cycles. The reverse oligo used in the latter reaction was the same in all the cases (616-R) 
which contains the FLAG sequence (indicated in bold letters). For the constructs 1b’’-9 
and 3-9, PCR reactions with oligos 577-578 and 325-616 respectively were carried out. 
The resulting PCR products were placed under the control of the CMV promoter by 
cloning into the pCR3.1 mammalian expression vector (Invitrogen).  
 
Oligo Nr. Location Sequence 
584-F exon1a 5´TAGCCAGGAGGTGTGGGTGCCTCCGTTGCGC 3´ 
582-R exon 3 5´CTGTTTGCAGGAATTCATGCAGTAAGTTTAATTTCTCC 3´ 
583-F exon 3 5´GCTCAAAGACTTGGAAAGAGATGGCTTAACAGAAAAG 3´ 
578-R exon 9 5´CTTCTTGTCATCGTCGTCCTTGTAGTCTCTGGTGTGA 3´ 
320-F exon1b 5’ ATGCGCGGGGCAGCGTTT 3’ 
316-R exon1b 5’ TAAAATAATAGGGCGGGGGC 3’ 
579-F exon1b 5’ GCCCGGCTGTCAAGTCCTAGGACCTTTTCTCTCTCAT 3’ 
578-R exon 9 5´CTTCTTGTCATCGTCGTCCTTGTAGTCTCTGGTGTGA 3´ 
579-F exon1b 5’ GCCCGGCTGTCAAGTCCTAGGACCTTTTCTCTCTCAT 3’ 
581-R exon1b 5’ TTCCCCTCTTCCGACTCTTCCTTGGGTTTCCGTTTAGT 3’ 
577-F exon1b 5’ GCCCCCGCCCTATTATTTTAGCCCCTGTAAACCAGT 3’ 
578-R exon 9 5´CTTCTTGTCATCGTCGTCCTTGTAGTCTCTGGTGTGA 3´ 
325-F exon 3 5’GAATCCCTGCAAACAGAAATAAAAAGCCAGTTGTGTGAC 3’ 
616-R FLAG 5’ CTTCTTGTCATCGTCGTCCTTGTAGTC 3’ 
 
All these constructs include exons 1b to 9 followed by the FLAG epitope sequence that is 
in frame with the Dnmt1 ORF and transcription is controlled by the CMV promoter (Fig. 
3.11B). In these constructs the expression of the FLAG epitope is only possible when 
translation initiation takes place at ATG4 in exon 4. As a positive control, a construct 
containing most of exon 1a of the ubiquitously expressed form was generated. Plasmid 
DNA was prepared from these constructs and used for transfection of COS-7 cells. Three 
days after transfection, expression of the FLAG tagged Dnmt1 protein was analyzed by 
immunofluorescence staining and Western blotting using an anti-FLAG mouse 
monoclonal antibody. All the constructs were able to generate tagged Dnmt1 truncated 
protein in COS-7 cells as indicated by the positive FLAG signal in the 
immunofluorescence images shown in Fig. 3.11D. The non-specific background 
fluorescence under the same conditions is shown in the image of the stained mock 
transfected COS-7 cells.  
Protein extracts from transfection experiments with a construct containing exon 1b’’ and a 
control containing instead exon 1a were compared by Western blot analysis with 
antibodies against the FLAG epitope tag. Both constructs, 1a-9 and 1b’’-9, gave rise to 
single bands on the western blot (Fig. 3.11C lanes 1 and 2 respectively). ATG4 is the 
only possible translation initiation site in the exon 1b constructs that is in frame with the 
FLAG epitope. These results clearly show that transcripts starting with exon 1b are 
Results 
 
 47
translatable and that a truncated Dnmt1 protein isoform is made, which could play an 
active role in the change of DNA methylation patterns during gametogenesis and 
myogenesis. 
 
Fig. 3.11. The skeletal muscle Dnmt1 transcript is translatable. Different expression 
constructs were designed to test whether the skeletal muscle isoform could generate a 
truncated Dnmt1 protein. (A)The strategy followed to generate some of the Dnmt1 
expression constructs is depicted. In the first PCR cycle all the reagents necessary for a 
PCR reaction but the flanking oligos were included. The first cycle allows the annealing 
and extension of the overlapping area between the two denaturated DNAs (DNA1 and 
DNA2). In the next cycles the oligos were added and amplification of the desired area 
occurs. (B) The different epitope tagged Dnmt1 expression constructs used to transfect 
COS-7 cells; 1a-9, 1b-9, 3-9, 1b’-9 and 1b’’-9 (b’ and b’’-9 correspond to nucleotides 651 
to 1418, respectively from GenBank sequence accession number AF 175432). The exons 
included in each of the constructs are indicated (see Fig. 3.10 for exon nomenclature). 
The dotted lines in exon 1b, which is found in testis and skeletal muscle cDNA, represent 
the areas which were deleted in the specific construct. The small flags at the end of each 
construct represent the 8-amino acid FLAG coding sequence which was added to each of 
them. ORFs starting at ATG2 and ATG4 in exons 1a and 4 respectively of the ubiquitous 
Dnmt1 isoform cDNA (Gaudet et al., 1998) and finishing in the FLAG tag are shown in 
thick lines and the short ORFs are shown in thin lines. The short vertical lines correspond 
to ATGs in the particular reading frame and the stars represent stop codons. The different 
expression plasmids were used for transient transfection of COS-7 cells. (C) The two 
types of Dnmt1 protein bands obtained are shown in the Western blot and were detected 
with the anti-FLAG M2 mouse monoclonal antibody, using the Dnmt1 constructs 1a-9 
(lane1) and 1b’’-9 (lane2). (D) Expression of the FLAG tagged Dnmt1 protein (thick lines) 
was analyzed by immunofluorescence staining with the anti-Flag M2 mouse monoclonal 
antibody. The DNA counterstaining was performed with Hoechst 33258 and the 
corresponding phase contrast (PC) images are also shown. The mock transfection is 
depicted at the top using similar conditions.  
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The results presented in this work indicate the presence of two transcripts of the Dnmt1 
gene whose expression varies substantially amongst the organs analyzed. Thus, high 
levels of expression of the ubiquitous transcript (5.4 kb) were detected in mouse brain 
and heart (Fig. 3.3). These results are in agreement with previous reports from Northern 
blot analyses in human tissues which showed that adult brain and heart express relatively 
large amounts of Dnmt1 mRNA (Yen et al., 1992). Furthermore, a new slower migrating 
transcript (6.2 kb) was identified in testis and skeletal muscle (Fig. 3.3). A similar longer 
transcript had been previously reported in spermatogenic cells (pachytene 
spermatocytes) of the testis (Trasler et al., 1992). The size difference between the 
ubiquitous and the new transcript shown by Northern blots suggests the presence of an 
alternative transcriptional start site or an alternative splice isoform in testis and skeletal 
muscle. Indeed, by RT-PCR and RACE a new Dnmt1 cDNA was isolated which differs in 
the first exon. Instead of the recently described exon 1 (Tucker et al., 1996; Yoder et al., 
1996) an alternative 800 bp long exon located downstream in the gene is present in this 
isoform indicating a new transcriptional start site. While this work was in progress, a 
similar cDNA was independently isolated from testis (Mertineit et al., 1998).  
The expression pattern of the new Dnmt1 isoform has been analyzed by in situ 
hybridization and found to be in the more specialized testis cells the haploid spermatids 
and at low level in skeletal muscle. The presence of a different Dnmt1 transcript in 
spermatids suggests that the function and regulation of Dnmt1 might be different in non-
replicating (spermatids) and in replicating spermatogonial cells. Interestingly, the same 
isoform is also expressed in terminally differentiated post-mitotic myotubes (Fig. 3.9). 
During gametogenesis the overall DNA methylation level increases and is higher in the 
male than in the female gametes (Fig. 1.5) (Monk, 1990). The presence of a new Dnmt1 
isoform in differentiating spermatids is suggestive of a role in these methylation pattern 
changes. 
The expression of the new Dnmt1 isoform was also investigated by in situ hybridization in 
embryo sections and the new transcript was localized in cartilages of the ear and hip. 
Interestingly, different patterns of methylation have been described for specific collagen 
genes at different stages of differentiation and dedifferentiation of chondrocytes 
(Fernandez et al., 1985). However, it remains to be tested whether the alternative Dnmt1 
isoform is involved in these methylation pattern changes.  
Dramatic changes in genomic methylation occur during development in oogenesis and 
spermatogenesis (Fig. 1.5). Therefore, it was important to investigate Dnmt1 isoform 
expression and localization at the protein level in both organs, testis and ovaries. In testis 
sections, by immunofluorescence studies, spermatogonia as well as spermatids showed 
the presence of Dnmt1 protein (Fig. 3.7). However, in the case of spermatids the 
fluorescence background is high making the discrimination of signals less clear. Other 
studies (Mertineit et al., 1998) showed also high levels of Dnmt1 protein in 
spermatogonia, preleptotene and leptotene spermatocytes but in contrast to this work no 
protein was detected in spermatids and pachytene spermatocytes where the new 
transcript is made.  
Ovaries from adult female mice were also analyzed for the presence of the Dnmt1 protein 
as shown in Fig. 3.6 where the Dnmt1 protein was localized mainly in the cytoplasm of 
mature oocytes and in the nucleus of lutein cells. Cytoplasmic retention of Dnmt1 protein 
in oocytes and preimplantation embryos has been previously reported (Carlson et al., 
1992) and shown to be due to the presence of a retention signal in the N-terminal 
regulatory domain of the protein (Cardoso and Leonhardt, 1999). This active retention of 
Dnmt1 in the cytoplasm correlates well with the overall decrease in the genomic 
methylation level and thus is a likely mechanism to regulate DNA methylation by 
separating Dnmt1 from chromosomal DNA in the nucleus. Demethylation might occur by 
preventing maintenance methylation of newly synthesized DNA strands or by preventing 
remethylation of actively demethylated sites.  
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Changes in DNA methylation occur not only during gametogenesis but also during 
differentiation. However, conflicting data have been published concerning the exact role 
of DNA methylation during differentiation. Thus on one hand, artificially induced 
demethylation seems to stimulate myogenic differentiation (Jones and Taylor, 1980), 
which is in accordance with the observation that the somatic Dnmt1 isoform is 
downregulated during myogenesis (Liu et al., 1996). On the other hand, forced 
overexpression of a truncated Dnmt1 protein, was shown to cause de novo methylation in 
the MyoD gene, upregulate its expression and stimulate myogenesis (Takagi et al., 
1995).  
In this work, a new alternative transcript was identified not just in testis but also in skeletal 
muscle (Fig. 3.3) and shown to be specifically upregulated during myogenesis, while the 
ubiquitous transcript is downregulated (Fig. 3.9). These results could reconcile the above 
contradiction, in the sense that the major Dnmt1 isoform responsible for maintenance of 
DNA methylation patterns is indeed downregulated but an alternative isoform with 
potentially different properties is upregulated.  
The sequence analysis of this alternative Dnmt1 isoform from skeletal muscle (Fig. 3.8) 
showed that it is actually identical to the one present in testis, which was published as 
untranslatable due to the presence of short upstream ORFs (Mertineit et al., 1998). 
These authors reported the inhibitory effect of upstream AUG codons based on the 
scanning model for translation initiation, in which the 43S pre-initiation complex enters at 
the 5’-cap structure of the mRNA and migrates in the 3’-direction to the first initiation 
codon that is present in an appropriate context (Kozak, 1991). Under some 
circumstances, however, an upstream AUG codon will reduce but not abolish initiation 
from downstream start codons. This happens when the first AUG codon is followed 
shortly by a terminator codon, creating a small open reading frame (ORF) at the 5’ end of 
the mRNA. One possible explanation is that, after an 80S ribosome translates the 5’-mini 
ORF, the 40S ribosomal subunit remains bound to the mRNA, resumes scanning, and 
may reinitiate at another downstream AUG codon downstream (Kozak, 1991). The 
translational status of the alternative Dnmt1 isoform was also analyzed experimentally 
(Trasler et al., 1992). These authors found that only ~15% of this Dnmt1 transcript was 
associated with polysomes and that a large portion of this transcript exist as free mRNPs, 
suggesting that this alternative transcript is translationally regulated. However, if inhibition 
of translation takes place in this alternative isoform it should also take place in the 
somatic and in particular in the oocyte isoform which contains several upstream AUG 
codons. Instead the Dnmt1 protein is present at very high levels in the oocyte (Fig. 3.6). 
Furthermore, the suppressive influence of upstream initiation codons might be regulated. 
The cells have other mechanisms to counteract suppression by an upstream ORF. Thus, 
an upstream ORF can be bypassed either through `leaky scanning´ or through the use of 
an internal ribosome entry site (IRES) (Geballe and Morris, 1994).  
When analysing these results together with the ones already published by other groups, it 
is clear that each experimental approach supports a different conclusion implicating 
technical factors. Thus, sedimentation profiles provide an accurate measure of 
translational activity but the most serious limitation is that the purified spermatogenic cells 
used for sucrose gradients contain a broad range of stages that could obscure 
translational differences in individual stages. This limitation could be overcome with the 
transillumination-assisted microdissection technique which permits the isolation of stages 
of spermatogenesis from freshly dissected seminiferous tubules (Mali et al., 1989). On 
the other hand, determining the stage of initial appearance of proteins and their mRNAs 
is subject to uncertainties caused by differences in the sensitivity of detection of mRNAs 
and proteins.  
It is interesting to notice that two independent promoters are used in different tissues 
(oocytes versus testis and skeletal muscle) to generate two different transcripts, which 
however, lead to the expression of the same shorter Dnmt1 isoform (Fig. 3.10). The 
expression of an alternative Dnmt1 isoform during oogenesis, myogenesis and 
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spermatogenesis however does not prove an active role in this process, especially since 
both isoforms have very similar biochemical properties in vitro (Pradhan et al., 1997). The 
shorter isoform seems to be able to substitute for the longer isoform during differentiation 
and to restore DNA methylation patterns in Dnmt1 null ES cells (Gaudet et al., 1998). 
Thus a specific role of the shorter isoform would require tissue-specific, interacting factors 
that could differentially interact with the Dnmt1 isoform and thus generate specificity. In 
this context is interesting to notice that the additional 118 amino acids of the longer 
isoform are highly conserved from sea urchin to human (Margot et al., 2000). Although 
the function of this amino acid stretch is not known, the presence of a putative leucine 
zipper suggests a role in protein-protein interactions which might be conserved 
throughout evolution.  
First hints for a role of the short Dnmt1 isoform during development were obtained by 
serendipity. Since the complete somatic Dnmt1 cDNA became known and available only 
in 1996 (Tucker et al., 1996; Yoder et al., 1996) a partial cDNA was used by other 
investigators for overexpression in myoblasts giving rise to a truncated Dnmt1 protein 
starting at ATG4, which is identical to the shorter isoform described here. The forced 
expression of this Dnmt1 isoform in myoblasts was shown to correlate with a high level of 
de novo methylation activity and to induce myogenic differentiation (Takagi et al., 1995). 
These experiments clearly show that the shorter Dnmt1 isoform from skeletal muscle 
cells can indeed induce myogenic differentiation.  
In the present work the tissue specific expression of Dnmt1 isoforms was shown which 
might play a role in the regulation of DNA methylation. However, further studies are 
needed involving selective Dnmt1 gene knock outs and the examination of enzymatic 
properties of both Dnmt1 isoforms in vivo. The elucidation of the Dnmt1 gene structure 
and the mapping of alternative transcriptional start sites carried out in this work make it 
now possible to study the transcriptional regulation and to characterize the tissue specific 
Dnmt1promoters. 
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